MOLECULAR CONTROL OF REGULATED EXOCYTOSIS IN ADIPOCYTES by LIM CHUN YAN
  
MOLECULAR CONTROL OF REGULATED 
EXOCYTOSIS IN ADIPOCYTES 
 
 
LIM CHUN YAN 
(B.Sc. (Hons.), NUS) 
 
 
A THESIS SUBMITTED 
FOR THE DEGREE OF DOCTOR OF PHILOSOPHY 
DEPARTMENT OF BIOCHEMISTRY 
YONG LOO LIN SCHOOL OF MEDICINE 










I hereby declare that this thesis is my original work and it has been 
written by me in its entirety.  
I have duly acknowledged all the sources of information, which have 
been used in the thesis. 






  _____________________________________ 
LIM CHUN YAN 




Many people have contributed to my work in different ways and I 
would like to take this opportunity to express my gratitude. 
 
First of all, I would like to thank my supervisor A/P Dr Han Weiping 
for his continuous guidance, and insightful discussions that have kept 
me on the right track. I greatly appreciate the opportunities of attending 
international conferences that benefit me in various aspects.   
 
I couldn’t be more thankful to my parents and my siblings for their 
unconditional love and encouragement in every step of my life. I am 
deeply indebted to my lifetime companion, Vivian Tay, for her love, 
patience, and relentless support to my career.  
 
Last but not least, I would like to thank all the colleagues and friends 
in Singapore Bioimaging Consortium, who have supported me during 
these years. I also want to acknowledge Dr Clement Khaw, and Ron 
Ng in Nikon Imaging Centre for their technical assistance on TIRF 
microscopy.  
 
Marie Curie once said: “ One never notices what has been done; 
one can only see what remains to be done.” As for myself, the journey 
in science is just about to begin.  
 IV 
List of Publications 
Chun-Yan Lim, Xuezhi Bi, Donghai Wu, Jae Bum Kim, Peter W 
Gunning, Wanjin Hong, and Weiping Han. “Tropomodulin3 is a novel 
Akt2 effector regulating insulin-stimulated GLUT4 exocytosis through 
cortical actin remodeling.” (2013, manuscript submitted) 
Kostromina, Elena, Natalia Gustavsson, Xiaorui Wang, Chun-Yan Lim, 
George K Radda, Cai Li, and Weiping Han. “Glucose Intolerance and 
Impaired Insulin Secretion in Pancreas-Specific Signal Transducer and 
Activator of Transcription- 3 Knockout Mice Are Associated with 
Microvascular Alterations in the Pancreas.” Endocrinology, 151 (2010), 
2050–2059 
Yang, Guoqing, Chun-Yan Lim, Chao Li, Xiaoqiu Xiao, George K 
Radda, Cai Li, Xinmin Cao, and Weiping Han. “FoxO1 Inhibits Leptin 
Regulation of Pro-Opiomelanocortin Promoter Activity by Blocking 
STAT3 Interaction with Specificity Protein 1.” The Journal of biological 
chemistry, 284 (2009), 3719–3727 
Ang, Boon K, Chun Y Lim, Sharon S Koh, Neelamegam Sivakumar, 
Shahrizan Taib, Kim B Lim, Sohail Ahmed, Guna Rajagopal, and Siew 
H Ong. “ArhGAP9, a Novel MAP Kinase Docking Protein, Inhibits Erk 
and P38 Activation Through WW Domain Binding.” Journal of 
molecular signaling, 2 (2007), 1 
Conference abstracts 
CY Lim, XZ B, Hong W, Han W: Phosphorylation of Tmod3 by Akt2 
regulates GLUT4 translocation by remodeling cortical actin. Abstract in 
the American Diabetes Association, the 72th Scientific Sessions, 
Philadelphia, 2012 (Oral Presentation) 
 
CY Lim, XZ B, Hong W, Han W: Tropomodulin 3 is a novel Akt2 
substrate modulating regulated exocytosis in adipocytes. Abstract in 
the Keystone Symposia of Pathogenesis of Diabetes, Santa Fe, New 
Mexico, 2012 (Poster) 
 
CY Lim, Hong W, Han W: Adiponectin is released via a unique 
regulated exocytosis pathway from a pre-formed pool of vesicles upon 
insulin stimulation. Abstract in the American Diabetes Association, the 




Table of Contents 
List of Publications ............................................................................ IV	  
Conference abstracts ........................................................................ IV	  
SUMMARY ........................................................................................... X	  
List of Tables .................................................................................... XII	  
List of Figures .................................................................................. XIII	  
ABBREVIATIONS .............................................................................. XV	  
CHAPTER I INTRODUCTION ............................................................... 1	  
1.1 Regulated Exocytosis ................................................................ 1	  
1.2 Insulin-stimulated GLUT4 translocation as principal 
mechanism of glucose disposal ..................................................... 3	  
1.3 Importance of Akt2 in insulin-stimulated GLUT4 
translocation .................................................................................... 7	  
1.4 Involvement of Cortical Actin in Regulated Exocytosis ...... 11	  
1.5 Aims .......................................................................................... 12	  
CHAPTER II MATERIAL AND METHODS ......................................... 13	  
2.1 Antibodies, Plasmids, and Reagents ..................................... 13	  
2.2 Cell Culture ............................................................................... 18	  
2.3 Lentivirus Packaging and Infection ....................................... 19	  
2.4 Protein purification .................................................................. 19	  
2.5 Mass Spectrometry Analysis .................................................. 21	  
2.6 In vitro GST Pull-Down Assay ................................................. 23	  
2.7 In vitro Protein Kinase Assay ................................................. 24	  
 VI 
2.8 In vitro Actin Crosslinking Assay ........................................... 24	  
2.9 In vitro Phospholipid Dot Blot Analysis ................................. 25	  
2.10 Immunofluorescence Microscopy ........................................ 26	  
2.11 TIRF/Wide-field Microscopy .................................................. 26	  
2.12 Myc-GLUT4-mCherry Translocation .................................... 27	  
2.13 Non-radioactive 2-Deoxyglucose Uptake Assay ................ 28	  
2.14 Plasma Membrane Fractionation ......................................... 29	  
2.15 Mouse work ............................................................................ 29	  
2.16 Gene Expression Analysis by RT-PCR ................................ 30	  
2.17 Statistical Analysis ................................................................ 30	  
CHAPTER III RESULTS ...................................................................... 31	  
3.1 Identification of Tmod3 as a novel Akt2 substrate ............... 31	  
3.1.1 Proteomic screening of new Akt substrate or functional 
partners in adipocytes .................................................................. 31	  
3.1.2 Tropomodulin 3 is a novel Akt2-interacting partner ............. 36	  
3.1.3 Akt2 phosphorylates Tmod3 in vitro .................................... 39	  
3.1.4 Akt2-mediated Tmod3 phosphorylation is regulated by insulin 
signaling in vivo ............................................................................ 41	  
3.1.5 Insulin-stimulated phosphorylation of Tmod3 is primarily 
mediated by Akt2 in adipocytes .................................................... 43	  
3.1.6 Insulin-stimulated phosphorylation of Tmod3 in mouse WAT 
in vivo ........................................................................................... 45	  
3.2 Insulin signaling modulates distribution of Tmod3 to 
membrane ruffles ........................................................................... 47	  
 VII 
3.2.1 Kinetics of Tmod3 phosphorylation and its association with 
activated Akt ................................................................................. 47	  
3.2.2 Tmod3 interacts with multiple phosphoinositides in vitro ..... 49	  
3.2.3 Insulin signaling regulates localization of Tmod3 to PIP3-rich 
structures at the cell periphery ..................................................... 51	  
3.2.4 Enhanced interaction of Tmod3 with Akt in response to 
insulin ........................................................................................... 53	  
3.3 Importance of Tmod3 in regulating insulin-stimulated 
glucose transport and GLUT4 translocation ............................... 55	  
3.3.1 Tmod3 clusters around cortical F-actin and co-localizes with 
GLUT4 at insulin-induced membrane ruffles ................................ 55	  
3.3.2 Tmod3 functions downstream of Akt signaling and is required 
for insulin-stimulated glucose transport ........................................ 57	  
3.3.3 Tmod3 plays a pivotal role in insulin-stimulated GLUT4 
exocytosis ..................................................................................... 59	  
3.3.4 Dissecting the site of action for Tmod3 in GLUT4 
translocation using TIRFM ............................................................ 61	  
3.3.5 Tmod3 is required for GLUT4 insertion into the PM but not 
the trafficking of GSVs to the periphery ........................................ 64	  
3.4 Roles of Tmod3 phosphorylation in insulin-stimulated 
glucose transport and GLUT4 translocation ............................... 66	  
3.4.1 Tmod3 phosphorylation modulates insulin-stimulated glucose 
transport ....................................................................................... 66	  
 VIII 
3.4.2 Phosphorylation of Tmod3 potentiates insulin-stimulated 
GLUT4 translocation ..................................................................... 68	  
3.5 Phosphorylation of Tmod3 regulates insulin-induced actin 
remodeling ...................................................................................... 70	  
3.5.1 Phosphorylation of Tmod3 regulates its binding to 
monomeric G-actin and nucleation of actin assembly .................. 70	  
3.5.2 Phosphorylation of Tmod3 regulates insulin-induced cortical 
actin remodeling in vivo ................................................................ 73	  
3.6 Identification of cognate Tropomyosin partner for Tmod3 in 
adipocytes ...................................................................................... 75	  
3.6.1 Tm5NM1 is the specific Tropomyosin partner for Tmod3 in 
adipocytes .................................................................................... 75	  
3.6.2 Tmod3 phosphorylation regulates its binding to Tm5NM1 .. 79	  
3.7 Tmod3: Tm5NM1 partnership is essential to insulin-
stimulated glucose transport and GLUT4 translocation ............ 81	  
3.7.1 Loss of interaction with Tm5NM1 does not affect Tmod3 
phosphorylation ............................................................................ 81	  
3.7.2 Tm5NM1-binding defective mutant of Tmod3 inhibits insulin-
stimulated GLUT4 translocation and glucose transport ................ 83	  
CHAPTER IV DISCUSSION ................................................................ 85	  
4.1 Essential Roles of Cortical Actin in Akt2-mediated GLUT4 
exocytosis ...................................................................................... 85	  
4.2 Significance of current study ................................................. 87	  
4.3 Future Work .............................................................................. 91	  
 IX 
4.4 Conclusion ................................................................................ 92	  











Regulated exocytosis is a fundamental cellular process by which the 
membranes of cytoplasmic vesicles fuse with the plasma membrane 
(PM), either releasing the contents into the extracellular space, or 
allowing the insertion of membrane protein in response to a trigger. My 
main research of interest lies in the mechanisms of insulin-regulated 
exocytosis in which its roles have been well exemplified in GLUT4 
translocation, which primarily occurs in skeletal muscle and adipose 
tissues and is essential for maintenance of whole-body glucose 
homeostasis and insulin sensitivity. At molecular level, insulin triggers a 
signaling cascade initiated from IRS-1/insulin receptor, promotes PI3K 
activities to generate PI(3,4,5)P3 (PIP3) membrane clusters for 
recruitment of Akt  to the PM. Activated Akt is capable of 
phosphorylating a number of downstream substrates and therefore 
modulating their functional activities. Among the three isoforms, Akt2 
turns out to play the most important role in directing insulin actions to 
promote GLUT4 translocation from intracellular storage compartment to 
the cell surface. In recent years, a handful of Akt2 substrate has been 
identified and found to be functionally involved in discrete steps of 
insulin-stimulated GLUT4 translocation. Dissecting the molecular 
mechanisms of insulin-regulated exocytosis is crucial to advance our 
understanding of glucose transport regulation and, more importantly, to 
enable us to pinpoint the major nodes of molecular defects that are 
responsible for impaired glucose uptake in insulin-resistant diabetic 
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patients. To identify new Akt substrates involved in GLUT4 
translocation, I established a condition mimicking insulin activation in 
cultured 3T3-L1 differentiated adipocytes by overexpressing a PM-
targeted Akt2 that is constitutively active and sufficient to promote 
spontaneous GLUT4 translocation. Using mass spectrometry 
approach, a list of potential Akt2-interacting partners or substrates was 
identified by analyzing the pulled-down complexes of Akt2. 
Tropomodulin 3 (Tmod3), a ubiquitously expressed actin-capping 
protein, was chosen as the subject of the current study for in-depth 
functional characterization. Taking a multidisciplinary approach, I 
demonstrated that Tmod3 is phosphorylated at Ser71 upon insulin-
stimulated Akt2 activation, and Ser71 phosphorylation is required for 
insulin-stimulated GLUT4 PM insertion and glucose transport. 
Phosphorylated Tmod3 regulates insulin-induced actin remodeling, an 
indispensable step for GLUT4 fusion with the PM, but not the trafficking 
of GSVs to the cell periphery. Insulin signaling modulates the spatial 
and temporal dynamics of Tmod3 and Tm5NM1, its cognate 
tropomyosin partner, to PIP3-rich membrane and such interaction is 
necessary for glucose transport. Together, these data establish that 
Tmod3 is a novel Akt2 effector that mediates insulin-induced cortical 
actin remodeling and subsequent GLUT4 membrane insertion. Current 
study suggests that defects in cytoskeletal remodeling may contribute 
to impaired GLUT4 exocytosis and glucose uptake. 
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CHAPTER I INTRODUCTION 
1.1 Regulated Exocytosis 
 
 
Vesicle exocytosis is one of the most fundamental intracellular 
mechanisms for delivery of cargo proteins to PM and extracellular 
environment (1). While most of the Golgi-derived vesicles are 
constantly targeted to the cell surface through constitutive exocytosis, 
there are some specific vesicles present in the cells to undergo 
exocytosis only in response to extracellular stimuli. The term of 
“regulated exocytosis” was coined to describe the acute mobilization of 
a specialized pool of vesicles that are enriched in particular proteins 
and/or lipids to the cell surface or extracellular space in response to 
stimulation. This controlled exocytosis plays a crucial role in regulating 
the secretion of soluble factors, delivery of intracellular membrane 
lipids and translocation of membrane proteins (Table 1-1). The most 
common characteristics for all the well-studied examples of regulated 
exocytosis are the requirements of specific signaling pathways that 
coordinate the action of proteins involved in vesicle biogenesis, 
trafficking, targeting, and fusion in a sequential and coupled manner. 
Uncovering these signaling pathways, which regulate the steps of 
exocytosis, is of utmost importance to understand how a variety of 
physiological processes take place.  
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Cell-type Stimulus Function 
Aquaporin-2 Kidney duct  Ca2+/cAMP Water readsorption 
Neurotransmitters  Neuron Ca2+ Synaptic activity 
Insulin Pancreatic 











Phagocytosis Macrophage GTP/PI3K Engulfment and 
cytokine release 






















1.2 Insulin-stimulated GLUT4 translocation as principal 
mechanism of glucose disposal 
 
 
One of the well-studied examples of regulated exocytosis is GLUT4 
translocation, which mediates insulin-stimulated glucose transport in 
muscle and adipose tissue. Despite daily fasting and feeding, blood 
glucose concentration is tightly regulated and maintained within a 
narrow range owing to the hormones insulin and glucagon. Following a 
meal, insulin is secreted from pancreas in response to rising blood 
glucose. Besides inhibiting gluconeogenesis in the liver, the prominent 
action of insulin is to promote glucose uptake in skeletal muscle and fat 
tissue through the regulated exocytosis of GLUT4 from intracellular 
storage compartments to the cell surface. Such facilitative event, 
termed insulin-stimulated GLUT4 translocation, apparently serves as a 
principal mechanism of glucose disposal to maintain euglycemia at 
physiological condition (2-4). 
GLUT4 glucose transporter (gene name: SLC2A4) confers the 
unique characteristic by redistributing to the PM from the intracellular 
disposition in response to insulin as compared to other isoforms of 
glucose transporter. The central role for GLUT4 as a key regulator of 
whole-body glucose homeostasis is strongly supported by a number of 
transgenic mouse models by which the GLUT4 expression is 
manipulated in vivo, either at whole-body or tissue-specific level. 
Although whole-body deletion of GLUT4 in mice shows compensatory 
features (5, 6), the fact that heterozygous GLUT4+/- mice display 
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insulin resistance and diabetes phenotype is consistent with a major 
role of GLUT4 in glucose disposal(7). Overexpression of GLUT4 in 
adipose tissue or in skeletal muscle increases insulin sensitivity and 
improves glucose tolerance in mice (8-11). By contrast, conditional 
knockout of GLUT4 in either adipose tissue or skeletal muscle induces 
insulin resistance (12, 13). Even though adipose tissue accounts for 
only a small fraction of total body glucose disposal as compared to 
skeletal muscle, it is remarkable that overexpression of GLUT4 in the 
adipose tissue of muscle-specific GLUT4 KO mice is sufficient to 
reverse the glucose intolerance and diabetes (14). This observation 
highlights the importance of adipose tissue in controlling whole-body 
energy homeostasis as adipocytes serve as a cellular “rheostat” that 
senses the nutrient and energy status, and responds through secreting 
numerous hormones and cytokines that regulate metabolism in liver, 
muscle and brain. Therefore, maintaining a proper insulin-regulated 
GLUT4 content on the adipocyte PM is regarded as a sensitive and 
highly reliable parameter of energy sensor for whole-body glucose 
homeostasis (4). In fact, GLUT4 mRNA and protein levels are 
exclusively downregulated in the adipose tissue, but not in the muscle 
of patients with type 2 diabetes (15-17). 
Impaired insulin-signaling pathway, which leads to defective 
GLUT4 translocation, manifests in patients with metabolic syndrome, 
and diet-induced obese animals, and many other transgenic animals 
associated with insulin resistance (18, 19). At molecular level, binding 
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of insulin to its tyrosine kinase receptor, insulin receptor (IR), results in 
tyrosine phosphorylation of insulin receptor substrate (IRS) proteins. 
Phosphorylated IRS proteins in turn activate phosphoinositide 3-kinase 
(PI3K), which convert phosphatidylinositol 4,5-bisphosphate (PIP2) to 
phosphatidylinositol (3,4,5)-triphosphate  (PIP3). The latter membrane 
clusters function as signaling platforms by recruiting the protein kinase 
B (Akt) to the PM, leading to the activation of Akt. Activated Akt is 
required to convey signals to downstream substrates and effectors in 
the process of insulin-stimulated GLUT4 translocation. Current model 
of insulin-mediated GLUT4 translocation as illustrated in Figure 1-2 
positions Akt to center stage in engaging the vesicle trafficking and 












Figure 1-2 Insulin regulates GLUT4 translocation by engaging the 






































1.3 Importance of Akt2 in insulin-stimulated GLUT4 translocation 
 
 
Given the critical role of GLUT4 regulation in diabetes development, 
significant efforts have been devoted to understanding the cellular 
events and molecular control of insulin-stimulated GLUT4 translocation. 
Multiple sites of insulin action have been exemplified in different steps 
of GLUT4 translocation including GLUT4 storage vesicles (GSVs) 
sorting, trafficking, tethering, docking, and finally fusion, mainly through 
insulin-enhanced protein-protein interactions or protein-GSV 
associations and more importantly, post-translational modifications 
such as phosphorylation of different molecular components involved in 
these steps. Upon insulin stimulation, protein kinase Bβ or Akt2, which 
is recruited to PM and becomes activated via phosphorylation at 
Ser473 and Thr308 residues by PDK-1 and mTORC2 respectively, 
plays a pivotal role in orchestrating the insulin actions by 
phosphorylating a number of downstream substrates whose functional 
activities are necessary for many discrete steps of GSV exocytosis (3). 
Several lines of compelling evidence have reiterated the 
indispensability of Akt2 for insulin-stimulated GLUT4 translocation and 
glucose transport, as demonstrated in a number of cell-based studies, 
in knockout mouse models, and in diabetic patients (20-25). Notably, 
PIP3 formation catalyzed by PI3Ks is required for GLUT4 insertion into 
the cell surface (26). Overexpression of a constitutively active form of 
Akt2 in adipocytes is sufficient to induce GLUT4 translocation and to 
increase glucose transport (27). Conversely, expression of a dominant 
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negative form of Akt2 inhibits GLUT4 translocation (25, 28). Moreover, 
siRNA-mediated knockdown (KD) of Akt2 induces more severe 
impairment of glucose transport and GLUT4 exocytosis in cultured cells 
than KD of Akt1 (29). In fact, Akt2 knockout mice display a diabetes-
like phenotype, which is not observed in Akt1 or Akt3 knockout mice 
(23). Last but not least, an inactivating mutation of Akt2 in human 
patients causes severe insulin resistance and diabetes (22).  
To date, only a handful of Akt2 substrates involved in GLUT4 
exocytic pathway has been identified (Table 1-3) and one of the most 
notable examples, AS160, a Rab-GTPase-activating protein, also 
known as TBC1D4 in adipocytes or TBC1D1 in myocytes, is involved in 
retention of GSVs at the basal state and phosphorylation of which 
results in activation of small Rab GTPases that facilitate the trafficking 
of GSVs to the cell surface (30). Further studies have also suggested 
that AS160 may be functionally related to GSV docking(31, 32). It is 
noteworthy that AS160-KD adipocytes has been shown to increase 
basal level of cell surface GLUT4 and yet these cells remain sensitive 
to Akt-inhibitor treatment (33), thus suggesting the presence of AS160-
independent step(s) and/or additional Akt2 substrate(s) may be 
required for optimal fusion of GLUT4 at the final stage of exocytosis. 
More recently, CDP138, a previously uncharacterized C2-domain 
containing protein in adipocytes was found to be an Akt2 substrate by 
SILAC approach, which may imply the involvement of calcium binding 
or sensing in GLUT4 vesicle fusion (34). Given the importance of Akt2 
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and its substrates in the regulation of glucose transport, there are 
continuing intensive efforts in identifying new Akt substrate(s) or other 
insulin-regulated phosphoproteins. Defining their functional roles in 
GLUT4 translocation will eventually advance the mapping of GLUT4 
circuitry and provide new mechanistic insights into deregulation of 



































Table 1-3. Akt substrates functionally involved in insulin-
stimulated GLUT4 translocation and glucose transport 
 
Substrate Function Proposed action Phosphorylation 
site 







Inhibit Syntaxin4 S99 
MyosinVa Actin-
motor  





Trafficking of GSVs S318 
CDP138 C2-domain 
protein 
Insertion of GLUT4 into 
PM 
S197 


















1.4 Involvement of Cortical Actin in Regulated Exocytosis  
 
 
With regard to its actions beneath the PM, insulin promotes GLUT4 
insertion by increasing the rate of vesicle fusion possibly by regulating 
cortical actin filament organization at the exocytotic sites (35-38). A 
number of actin filament inhibitors have been shown to inhibit GLUT4 
translocation and glucose transport in response to insulin stimulation 
(39, 40). Notably, cortical actin disruption by Latrunculin B treatment 
significantly reduces vesicle fusion events but not the trafficking of 
GLUT4 vesicles to the cell cortex of adipocytes, indicating the critical 
requirement of the formation of new actin filaments (41). Furthermore, 
studies of GSVs dynamics demonstrate that the actin filaments are 
most likely involved in the tethering of vesicles close to the PM (18). 
The myosin motor Myo1c (42, 43) has recently been shown to mediate 
insulin-induced tethering of GSVs to sub-membranous actin filaments 
(44). Although insulin induces rapid and dynamic remodeling of actin 
filaments into cortical mesh, which is necessary for GLUT4 
translocation (45), the molecular mechanistic links between insulin/Akt 
signaling and actin remodeling are yet to be elucidated. However, 
discoveries of the involvement of motor proteins such as MyosinVa and 
Myo1c in GLUT4 exocytic pathway (42, 43, 46) have shed light on the 
potentially important roles for a subset of actin-binding proteins that are 






The main objective of current study is to identify new Akt2-interacting 
partners or substrates and to characterize their functional roles in 
insulin-stimulated GLUT4 translocation and glucose transport. Specific 
aims of the study are listed as follows: 
1. To determine whether Tmod3 is an Akt2 substrate 
2. To study the importance of Tmod3 in insulin-stimulated GLUT4 
translocation and glucose transport 
3. To understand how phosphorylation of Tmod3 contributes to actin 
remodeling required for vesicle fusion  
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CHAPTER II MATERIAL AND METHODS 
2.1 Antibodies, Plasmids, and Reagents 
 
 
All the antibodies and plasmids used in this study were listed in Table 
2-1. All chemicals were purchased from Sigma unless otherwise 
stated. 
Table 2-1. A list of antibodies and plasmids used in the study 
 
Antibodies Isotype Applications Source 
Anti-FLAG M2 
Affinity Gel 
Mouse IP Sigma 




Mouse IP Sigma 
Anti-Tubulin Mouse WB Sigma 
Anti-HA.11, clone 
16B12 
Mouse WB Covance 
Anti-HA Mouse WB Cell Signaling 
Anti-Akt Rabbit WB Cell Signaling 
Anti-pS473-Akt Rabbit WB/IF Cell Signaling 
Anti-pT308-Akt Rabbit  WB Cell Signaling 
Anti-Akt1 Rabbit WB Cell Signaling 
Anti-Akt2 Rabbit WB Cell Signaling 
Anti-phospho-Akt-
substrate (PAS) 
Rabbit  WB Cell Signaling 
Anti-GSK3 beta Rabbit  WB Cell Signaling 
Anti-phospho-GSK3 
beta 
Rabbit  WB Cell Signaling 
Anti-IRAP Rabbit WB Cell Signaling 
Anti-Tropomyosin1/3 Rabbit WB Cell Signaling 
Anti-IR beta Mouse WB Santa Cruz 
Anti-phospho-IR beta Mouse WB Santa Cruz 
Anti-PPAR gamma Rabbit WB Santa Cruz 
Anti-C/EBPα Rabbit WB Santa Cruz 
Anti-GLUT4, N-20 Goat  IF Santa Cruz 
Anti-beta actin Mouse  WB Santa Cruz 
Anti-adiponectin Rabbit  WB Santa Cruz 
Anti-GST Mouse WB Santa Cruz 
Anti-Myo1c Mouse WB Santa Cruz 
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Anti-Myc, clone 9E10 Mouse WB/IF Santa Cruz 
Anti-Tmod3 Rabbit WB/IP AVIVA 
Anti-GLUT4, clone 
1F8 
Mouse WB/IP/IF R&D Systems 
Anti-γTm9d for 
detection of Tm5NM1 
Mouse WB Peter W.Gunning 
(47) 
Anti-δTm9d for 
detection of Tm4 
Rabbit WB 
Anti-CG1 for 
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2.2 Cell Culture 
 
 
3T3-L1 fibroblasts (ATCC) were cultured and differentiated into 
adipocytes according to standard protocols. Briefly, 3T3-L1 fibroblasts 
were cultured in high-glucose DMEM (Invitrogen, GIBCO) 
supplemented with 10% newborn calf serum at 37°C and 5% CO2. Two 
days after confluence, cells were washed with PBS two times and 
switched into differentiation medium containing 10% fetal bovine 
serum, 1 μM insulin, 0.5 mM 3-isobutyl-1-methylxanthine, and 1 μM 
dexamethasone for two days. Cells were replaced with media 
containing 10% fetal bovine serum and 167 nM insulin for another two 
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days. Cells were then maintained in DMEM with 10% fetal bovine 
serum. Adipocytes were used for experiments at day ten post-
differentiation. HEK293T and CHO-IR cells were cultured in DMEM 
with 10% fetal bovine serum. 
 
 
2.3 Lentivirus Packaging and Infection 
 
 
Lentiviruses were produced by co-transfecting HEK293T cells with 
lentiviral expression and packaging plasmids using the calcium 
phosphate transfection method as described previously (50, 51). Viral 
supernatant was collected after 24 hr transfection and centrifuged at 
1000 x g for 5 min and filtered with 0.45 μm filter. The viruses were 
further concentrated by ultracentrifugation using SW41 swinging rotor 
in Beckman Coulter Optima-L-100 XP at 26,000 RPM for 2 hr at 20°C. 
3T3-L1 adipocytes at day four of differentiation were transduced with 
appropriately titrated viruses in the presence of 4 μg/ml of polybrene. 
Cells were removed of viruses after 48 hr incubation and replaced with 




2.4 Protein purification 
 
 
(A) Enrichment of FLAG-Akt2-CA and its associated complexes for 
mass spectrometry study: 3T3-L1 adipocytes at day four were infected 
with lentivirus expressing FLAG-Akt2-CA and harvested at day ten. 
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Cells were lysed in TNET buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl, 
1 mM EDTA, 10 mM NaF, 1% Triton X-100) containing 1 mM Na3VO4, 
1 mM PMSF, and 1x protease inhibitor cocktail tablet (Roche). Cleared 
supernatant was used for immunoprecipitation with anti-FLAG M2 
beads. Bound complexes were washed extensively with TNET buffer 
and eluted with 3X FLAG peptide in 20 mM NH4HCO3, pH 8.3. The 
eluate of the samples was subjected to mass spec analysis.  
(B) Preparation of HA-/FLAG-tagged proteins from HEK293T cells: HA- 
and FLAG-tagged proteins were expressed in HEK293T cells and 
purified using EZview Red Anti-HA Affinity Gel or anti-FLAG M2 beads, 
respectively. Proteins were subsequently eluted with HA-peptide or 3X 
FLAG peptide in TBS buffer (50 mM Tris-Cl, pH 7.5, 150 mM NaCl). 
Protein concentrations were measured using Bradford assay.  
(C) Recombinant GST-fusion protein purification: Full-length mouse 
Tmod3 and mutants were inserted in-frame in the linker region of 
pGEX-KG vector so as to encode a fusion protein with GST on the N-
terminus. GST fusion Tmod3 and mutants were expressed in BL21 
Escherichia coli and induced for protein production with 1 mM IPTG for 
2 hr when the OD600 of bacteria growth reached approximately ~1.00. 
Bacteria were then harvested and proteins were purified using 
standard protocol. Briefly, bacteria pellets were suspended in Buffer A 
(20 mM Tris-Cl, pH 8.0, 0.1 M NaCl, 1 mM DTT) containing 1 mM 
PMSF and 1x protease inhibitor cocktail tablet (Roche) and incubated 
with 0.25 mg/ml lysozyme on ice for 30 min. The bacterial lysate was 
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sonicated on ice using an ultrasonic processor Vibra-Cell VCX130 
(SONICS & MATERIALS, Inc) with 8 cycles of a 30 second pulse 
followed by a 10 second break at 40% amplitude output for 4 minutes. 
The lysate was treated with 0.5 % Triton X-100 and rocked at 4°C for 
15 min. The lysate was cleared by centrifugation at 14,000 RPM, at 
4°C for 30 min. The pre-equilibrated glutathione-Sepharose 4B beads 
(GE Healthcare) in Buffer A with 0.1% Triton X-100 were incubated 
with clear supernatant for 1 hr at 4°C. GST-fusion proteins were bound 
to glutathione beads and eluted by thrombin cleavage (GE Healthcare) 
in TTB buffer (20 mM Tris-Cl, pH 8.0, 150 mM NaCl, 2.5 mM CaCl2). 
Thrombin was then removed using Benzamidine-Sepharose beads (GE 
Healthcare). Thrombin-free eluted proteins were further concentrated 
using appropriate centrifugal filter units (Amicon Ultra, Millipore). 
Protein concentrations were measured prior to the assays. 
 
 
2.5 Mass Spectrometry Analysis 
 
 
(A) SDS-PAGE gel based ID: FLAG-tagged constitutively active form of 
Akt2 and its associated protein complexes were pulled down using 
anti-FLAG M2 beads and released with glycine-HCl, pH 3.0. The eluate 
of the samples, approximately about 100 μg, was lyophilized at -80°C 
and reconstituted in 30 μl of SDS sample buffer, resolved in 4-15% 
TGX gradient SDS-PAGE, and detected with silver staining. Visible 
bands were excised from the gel, subjected to reduction with 25 mM 
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DTT at 56°C and alkylation with 55 mM iodoacetamide (IAA) in the 
dark at room temperature, followed by in-gel digestion with trypsin 
(Promega, mass spectrometry grade), 10 ng/μl in 25 mM ammonium 
bicarbonate buffer, pH 8.0 for 16 hr at 37°C. Peptides were extracted 
and spotted onto MALDI target plate with HCCA as matrix. MALDI-
TOF-TOF MS/MS were carried out at Bruker Ultraflex III TOF-TOF with 
supports of software including FlexControl 3.0, FlexAnalysis 3.0 and 
Biotools 3.2. Processed spectra peak lists were submitted to in-house 
Mascot server for database search.  
(B) Shotgun LC-Q-TOF MS/MS based ID: Protein complexes of Akt2 
from another batch of cell lysate were pulled down and directly eluted 
in the 25 mM ammonium bicarbonate buffer with 3X FLAG peptide. 
After freeze-drying, the protein mixtures were denatured in the 20 μl of 
ammonium bicarbonate buffer containing 0.1% SDS and 25 mM DTT at 
95°C for 5 min, and digested with 2 μg trypsin (Promega) for 16 hr at 
37°C. Peptide mixtures were acidified by adjusting the concentration of 
0.1% TFA, and then injected to Waters SYNAPT Q-TOF MSMS 
analysis with the mobile phase B (acetonitrile + 0.1% FA) gradient from 
5% to 60% over 60 min in nanoACQUITY UPLC BEH130 C18 column 
(1.7µm, 75µm x 150mm). The Masslynx generated pkl files were 
submitted to Mascot server for protein ID.  
(C) Detection of spectra of Phospho-Ser71 of Tmod3: FLAG-tagged 
Tmod3 proteins were purified from HEK293T transiently co-expressing 
FLAG-Tmod3 and constitutively active form of Akt2 (myr-HA-Akt2) 
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using anti-FLAG M2 beads. Proteins were eluted in 25 mM ammonium 
bicarbonate buffer, concentrated by Vivaspin2 30 kDa MWCO PES 
ultrafiltration spin-column (Sartorius Stedium Biotech GmbH, Germany) 
to 50 µl, treated with 20mM DTT for 10 min at 60°C, and alkylated in 20 
mM iodoacetamide for 30 min in the dark at room temperature. 
Samples were then incubated with 1 µg trypsin for 16 hr at 37°C. 
Peptide mixtures were extracted with C18 ZipTip®pipette tips 
(Millipore) after acidification with TFA and drying, and reconstituted 
with 0.1% Formic acid, followed by HPLC CHIP with 150mm x 75µm 
ReproSil-Pur C18-AQ 5µm separation on Agilent 1260 Infinity 
Nanoflow LC and analyzed on 6520 Q-TOF MS/MS. Spectra were 
processed with MassHunter workstation software (Agilent) and 
exported in mzData format for Mascot database search. 
Carbamidomethyl cysteine was set as fixed modification whereas 
oxidized methionine, N-acetyl amino acids, and phospho-STY, were 
searched as variable modifications. Peptide mass tolerance was set to 
±100 ppm and fragment mass tolerance was set to ±0.2 Da. A 
maximum of three missed cleavages was allowed. 
 
 
2.6 In vitro GST Pull-Down Assay 
 
 
GST fusion proteins were produced and purified from bacteria lysates 
with glutathione resin (GE Healthcare) (see Section 2.4).  The 
glutathione beads coupled to GST fusion proteins were equilibrated 
with TNET buffer and then incubated with appropriate amount of cell 
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lysates for indicated time at 4°C. Pull-down samples were collected 
and washed four times with TNET buffer. Samples were subjected to 
SDS-PAGE and western blot analysis. 
 
 
2.7 In vitro Protein Kinase Assay 
 
 
In vitro kinase assays were performed on purified HA-tagged Tmod3 
wild-type and mutant proteins. Briefly, 1 μg of HA-Tmod3 and 50 ng of 
purified FLAG-Akt2-CA were incubated in 50 μl of volume reaction in 
kinase buffer (25 mM Tris-Cl, pH 7.5, 5 mM β-glycerophosphate, 2 mM 
DTT, 0.1 mM Na3VO4, 10 mM MgCl2) containing 0.2 mM ATP. The 
kinase reaction was incubated at 30°C for 30 min and boiled in SDS 
sample buffer and separated by SDS-PAGE. GSK-3β fusion protein 
(GSK-3β FP, Cell Signaling) was used as a positive control. Phospho-
signals were detected using anti-PAS Ab, (Cell Signaling). As for 
radioactive approach, the sample mixtures were incubated in the 
kinase buffer with 10 μCi [32P] γ-ATP (PerkinElmer, SG) for 30 min at 
30°C. Samples were analyzed by SDS-PAGE and autoradiography. 
 
 
2.8 In vitro Actin Crosslinking Assay 
 
 
Purified non-muscle actin from human platelet was purchased from 
Cytoskeleton, Inc. Each protein sample was centrifuged at 300,000 x g 
at 4°C for 2 hr to remove aggregates, and protein concentrations were 
determined by spectrophotometry. Cross-linking of G-actin to Tmod3 
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was performed as described previously with slight modifications (52). 
Briefly, G-actin and Tmod3 proteins were exchanged into a buffer 
containing 5 mM HEPES, pH 7.5, 0.1 mM CaCl2, 0.2 mM ATP, and 0.2 
mM DTT using protein desalting spin columns (Pierce). G-actin and 
Tmod3 were mixed at a 1:1 molar ratio at concentrations between 10 
and 20 μM for 20 min at RT. Crosslinking stock solutions of EDC and 
sulfo-NHS (Pierce) were freshly prepared and added to the reaction at 
a final concentration of 1 mM for additional 45 min at RT. Reactions 
were terminated by adding 2X SDS sample buffer followed by SDS-
PAGE.  Assays using GST-Tmod3 proteins were performed similarly 
except that the proteins were bound to glutathione beads.  
 
 
2.9 In vitro Phospholipid Dot Blot Analysis 
 
 
Phosphoinositide membrane strips were purchased from Invitrogen. 
Briefly, the membranes were blocked with TBST + 3% BSA for 1 hr at 
room temperature prior to incubation with 50 μg/ml of GST-fusion 
proteins at 4°C overnight. GST-fusion proteins were eluted from 
glutathione beads with 25 mM glutathione and subjected to buffer 
exchange with TBS beforehand. After extensive washing, membranes 
were incubated with anti-GST mouse antibody, washed, and probed 
with anti-mouse IgG conjugated with HRP. Detection of lipid binding 




2.10 Immunofluorescence Microscopy 
 
 
For co-localization studies, adipocytes plated on 1% gelatin-coated 
coverslips were serum-starved before insulin treatment. Cells were 
fixed with 4% paraformaldehyde, washed with PBS and blocked with 
PBS containing with 2% FBS and 0.02% sodium azide for at least 1 hr. 
Cells were then permeabilized with 0.1% saponin in PBS and stained 
with relevant antibodies followed by Alexa Fluor secondary antibodies 
accordingly. After washing, the coverslips were mounted with DAKO 
mounting medium (DAKO). Optical sections of samples were taken 
through sequential scans at respective wavelengths using a Nikon 
A1R-A1 confocal laser microscope system with a 100x NA/1.40 CFI 
Plan APO VC oil-immersion objective. 
 
 
2.11 TIRF/Wide-field Microscopy 
 
 
Total internal reflection fluorescence microscopy setup was based on 
Nikon Eclipse-Ti inverted microscope with two EMCCD cameras (1002 
x 1002, 8 x 8 μm, 14-bit, Andor iXonEM + 885; Andor Technologies) 
capable of capturing two channels (TIRF laser 488nm; TIRF laser 561 
nm) simultaneously. Both TIRF and Epifluorescence images were 
captured using a 100x NA/1.49 APO TIRF oil-immersion objective. 
Immersion oil (nd = 1.515, Nikon) was used to bridge the optical 
contact between the objective and the coverslip. The penetration depth 
of the evanescent field was estimated to be ~200 nm. Images were 
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acquired with no binning, at 27 MHz readout rate with average 
exposure times vary between 30 ~ 50 ms. Cells were reseeded to grow 
in 35 mm glass-bottom dishes (MatTEK) for two days before imaging. 
Cells were serum-starved for 2 hr and incubated in imaging buffer for 
live-cell recording at 37°C with different treatment. Cells were kept in a 
Tokai Hit temperature controlled incubation box at 37°C supplemented 
with 5% CO2.  
 
 
2.12 Myc-GLUT4-mCherry Translocation 
 
 
To examine the effect of KD of Tmod3 or expression of Tmod3 mutants 
on GLUT4 translocation, cells were transduced with lentivirus encoding 
shRNA against Tmod3 or Tmod3 mutants accordingly. In non-
permeabilized condition, cells were incubated with primary mouse anti-
Myc Ab (9E10) and Alexa Fluor 488-conjugated anti-mouse secondary 
Ab. Mounted samples were subjected to confocal imaging. Nikon 
Element software was used for quantitative measurements of GLUT4 
translocation. Briefly, cells expressing myc-GLUT4-mCherry were 
selected for measurement of fluorescence intensity of both Myc- and 
mCherry after removal of background fluorescence. The Myc/mCherry 
ratio was calculated for each cell and average over multiple cells for 
each experiment. 
For fixed cells under TIRF microscopy, the ratio of TIRF-Myc/Epi-
mCherry was measured by dividing the fluorescence intensity of TIRF-
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2.13 Non-radioactive 2-Deoxyglucose Uptake Assay 
 
 
Non-radioactive 2-deoxyglucose uptake assays were conducted as 
described previously (53). Infected adipocytes were seeded on 12-well 
plates and serum-starved for 3 hr. Cells were washed 3 times with 
warm KRPH (Krebs Ringer Phosphate HEPES) buffer (1.2 mM 
KH2PO4, 1.2 mM MgSO4, 1.3 mM CaCl2, 118 mM NaCl, 5 mM KCl, 30 
mM HEPES, pH 7.5). Cells were then incubated with 1ml KRPH buffer 
containing 2% BSA at 37°C and stimulated with or without 100 nM 
insulin for 20 min. Glucose uptake was initiated by addition of 1 mM 2-
deoxyglucose for 20 min at 37°C. Assays were terminated by washing 
cells with cool PBS 3 times, the cells per well were lysed with 0.5 ml of 
10 mM Tris-HCl, pH 8.0 supplemented with 0.5% Triton X-100 and 
subjected to heat treatment at 80°C for 15 min. Lysate were then 
centrifuged at 15,000 x g for 20 min at 4°C. 40 x dilution of samples 
were used for measurement of 2-deoxyglucose uptake using the non-
radioactive 2-deoxyglucose uptake ELISA kit (Cosmo Bio Co., LTD. 
Japan) according to manufacturer’s instructions. Non-specific 2-
deoxyglucose-uptake was measured in the presence of 20 μM 




2.14 Plasma Membrane Fractionation 
 
 
All the procedures of differential centrifugation were conducted at 4ºC 
(54). Cells after treatment were washed three times with HES buffer 
(20 mM HEPES, pH 7.4, 250 mM sucrose, 1 mM EDTA) and scrapped 
with a rubber policeman in the same HES buffer supplemented with 
Complete protease inhibitors mixture, 1 mM PMSF, 1 mM sodium 
orthovanadate, 10 mM sodium fluoride, 10 mM β-glycerol phosphate. 
Cells were homogenized with a Dounce homogenizer. Cell 
homogenate was centrifuged at 19000 x g for 20 min at 4ºC and the 
resulting pellet was washed with HES buffer and centrifuged at 19000 x 
g for 20 min. The final pellet was re-suspended and loaded on a 1.12 M 
(38.5% wt/vol) sucrose cushion and centrifuged at 100 000 x g for 60 
min using a SW41 rotor to generate plasma membrane fraction (PM). 
The PM fractions obtained were then permeabilized with 1% Triton X-
100 and subjected to immunoprecipitation. 
 
 
2.15 Mouse work  
 
 
Mice used in this study were maintained in animal facility of Biological 
Resource Centre, A*STAR. All animal experiments were conducted in 
accordance with regulation of the Institutional Animal Care and Use 




2.16 Gene Expression Analysis by RT-PCR 
 
 
Total RNA from 3T3-L1 adipocytes was extracted using Trizol Reagent 
(Invitrogen). One μg of RNA after DNase I treatment was used for first 
strand cDNA synthesis using Applied Biosystems TaqMan Reverse 
Transcription Reagents. A 10X-diluted cDNA of samples was subjected 
to real-time PCR using SYBR Green dyes with appropriate primers. 




2.17 Statistical Analysis 
 
 
Data are expressed as means ± SEM unless otherwise stated. 
Statistical analyses were performed by using Student’s test or one-way 
ANOVA for group comparisons. The level of statistical significance was 






CHAPTER III RESULTS 
3.1 Identification of Tmod3 as a novel Akt2 substrate  
 
3.1.1 Proteomic screening of new Akt substrate or functional 
partners in adipocytes 
 
 
In an effort to search for novel Akt substrates that may be functionally 
involved in insulin-stimulated GLUT4 translocation, a small-scale 
proteomic screening was undertaken in cultured 3T3-L1 differentiated 
adipocytes overexpressing FLAG-tagged constitutively active form of 
Akt2 (myristoylated human Akt2, FLAG-Akt2-CA) by lentiviral 
transduction. Activation of Akt2 upon recruitment to the PM is sufficient 
to stimulate GLUT4 translocation and increase glucose transport in 
3T3-L1 adipocytes to an extent similar to insulin stimulation (55). 
Expression of Akt2 carrying a myristoylation sequence at the N 
terminus allows the membrane targeting of the protein and results in 
spontaneous phosphorylation by PDK-1 and mTORC2 complex, 
therefore mimicking the sustained effects of insulin-induced PM 
recruitment of Akt2. Under such circumstance, it is conceivable that a 
full-fledged panel of substrates or functional partners of Akt2 would be 
activated in parallel so as to increase cell surface GLUT4 protein level 
(Figure 3-1-1). Hence, the protein complexes of constitutively active 
Akt2 can be enriched by immunoprecipitation prior to mass 
spectrometry analysis. 
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Figure 3-1-1 A schematic illustration depicts the strategy for 
identifying new Akt substrates or its interacting partners in 
adipocytes using mass-spec approach 
3T3-L1 adipocytes expressing a FLAG-tagged constitutively active 
form of Akt2 were harvested, lysed and subjected to 
immunoprecipitation using anti-FLAG M2 beads. Protein complexes of 




































Briefly, 3T3-L1 adipocytes at day four of differentiation were 
infected with lentivirus expressing either FLAG-Akt2-CA or Mock vector 
for two days, and subsequently maintained with medium replacement 
every two days thereafter. Infected cells were harvested at day ten 
post-differentiation and cell lysate from both groups were subjected to 
immunoprecipitation (IP) using anti-FLAG M2 beads. To identify Akt2-
interacting partners/substrates, two methods, namely, SDS-PAGE gel-
based ID, and shotgun LC-Q-TOF MS/MS based ID, were applied, 
respectively. Eluted proteins from first batch of samples were run on 
SDS-PAGE and silver-stained protein bands were excised and 
digested by trypsin for mass spectrometry  (MS) analysis. On the other 
hand, another batch of samples was examined using shotgun 
approach by which the eluted proteins were directly subjected to in-
solution trypsin digestion before being applied to liquid chromatography 
coupled tandem MS. Combining the results of target identification by 
these complementary approaches, a total number of 34 proteins was 
identified as putative interacting partners of constitutively active form of 














Table 3-1 Proteins identified as putative interacting partners or 




1 P36993 PPM1B Phosphatase 
2 P35908 KRT2 Keratin Type II 
3 Q14681 KCTD2 Potassium channel 
4 Q8BTI8 SRRM2 Pre-mRNA splicing 
5 Q9JHJ0 TMOD3# Actin-capping 
6 P04797 GAPDH Glycolysis 
7 A2Q0Z1 HSPA8 Heat-shock protein 
8 P06761 GRP78 Protein assembly in ER 
9 A2BDB0 ACTG1 Gamma Actin 
10 A5PKG7 KCTD5 Substrate adapter in E3 ligase 
complex 
11 Q91VJ4 STK38 Negative regulator of MAP3K1/2 
signaling 
12 P52873 PC Pyruvate carboxylase 
13 P35527 KRT9 Keratin, Type I 
14 Q8BMS1 HADHA Trifunctional enzyme subunit alpha, 
mitochondrial 
15 Q5FTY1 TUF Elongation factor in protein synthesis 
16 P02550 TUBA1A Alpha-tubulin 1 
17 Q99MR8 MCCC1 Methylcrotonoyl-CoA carboxylase 
subunit alpha, mitochondrial 
18 O35501 GSPA9 Stress-70 protein, mitochondrial 
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19 A2Q0Z0 EEF1A1 Elongation factor 1-alpha 1 
20 Q3ULD5 MCCC2 Methylcrotonoyl-CoA carboxylase 
beta chain, mitochondrial 
21 Q4V8H8 EHD2 Membrane trafficking and 
reorganization 
22 Q9W7L0 ENOA Alpha-enolase 
23 Q13370 PDE3B cAMP/cGMP phosphodiesterase 
24 P19483 ATP5A1 ATP synthase subunit alpha, 
mitochondrial 
25 P14105 MYH9 Myosin heavy chain 9 
26 Q8BFR5 TUFM Elongation factor Tu, mitochondrial 
27 Q5F2F2 ABHD15 AB hydrolase 
28 P0CB50 PRDX1 Peroxiredoxin-1, redox regulation 
29 Q8N5Z5 KCTD17 Potassium channel 
30 Q4R4T5 HSP90AB1 Heat shock protein 
31 Q2SBR2 RNHB Ribonuclease HII 
32 Q60994 ADIPOQ Adiponectin 
33 P10639 TXN Thioredoxin 
34 Q2KJD0 TUBB5 Tubulin beta-5 chain 
#Tropomodulin 3 (TMOD3), Q9JHJ0, highlighted in purple color in the 








3.1.2 Tropomodulin 3 is a novel Akt2-interacting partner 
 
 
Of all the IDs, a protein named Tropomodulin 3 (Tmod3, or U-Tmod), 
whose size corresponds to a molecular weight of 40 kDa, as a hit of an 
Akt2-interacting protein with significant peptide matches, was selected 
as the target of this study, given the fact that it is an actin binding 
protein and insulin-induced actin remodeling is an important event 
contributing to GLUT4 exocytosis (Table 3-1 and Figure 3-1-2A). 
Tropomodulin is an actin-capping protein that binds and caps the 
pointed end of actin filaments specifically, regulating the length, 
stability, architecture, and geometry of membrane cortical actin. In 
contrast to other isoforms which are tissue-specific, Tmod3 is 
ubiquitously expressed in a variety of tissues and cell types (56, 57). 
Indeed, Tmod3 was found to be present in 3T3-L1 preadipocytes and 
differentiated adipocytes. Tmod3 expression level remained unaltered 
throughout the process of adipogenic differentiation, as analyzed by 
RT-PCR and western blot (Figure 3-1-2B-C). Sequence analysis 
revealed the presence of an Akt consensus phosphorylation motif 
[RERLLS*, Ser71] located within α-helix2 region near the N terminus 
(amino acid position 67 to 77) in Tmod3. The phosphorylation motif is 
unique for Tmod3, but absent in other tropomodulin isoforms (Figure 3-
1-2D).  
Although the kinase-substrate relationship may be transient as 
Tmod3 was identified thru pull-down, an in vitro GST-pull down assay 
was first conducted to examine whether Akt2 interacts directly with 
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Tmod3. Bacterially purified GST- and GST-Tmod3 were captured by 
glutathione beads accordingly and incubated with lysates of HEK293T 
expressing FLAG-tagged Akt1 or Akt2, respectively. As shown in 
Figure 3-1-2E, GST-Tmod3 pulled down both Akt1 and Akt2 proteins, 
and in fact Akt2 showed higher binding affinity towards Tmod3. 
Collectively, these data suggest that Tmod3 is a new Akt2-interacting 































Figure 3-1-2 Tmod3 is a novel Akt2-interacting partner in 
adipocytes 
(A) Tmod3 is identified as one of the interacting partners of Akt2 using 
mass spectrometry (MS)-based approach. Silver-stained gel of affinity-
purified Akt2-protein complexes from two groups of 3T3-L1 adipocytes 
(Mock versus FLAG-Akt2-CA: Overexpression of a constitutively active 
Akt2, human) is shown. Bands corresponding to phospho-Akt2 and 
Tmod3 are indicated. (B) Steady expression of Tmod3 in 3T3-L1 
preadipocytes and differentiated adipocytes. Expression of various 
genes in both 3T3-L1 preadipocytes and differentiated adipocytes was 
analyzed by real-time quantitative PCR (qPCR) (n = 7 per group). (C) 
Protein expression at different stages of 3T3-L1 adipocyte 
differentiation was examined from day zero to day ten. Tubulin was 
used as a loading control. (D) Schematic domains of Tmod3 protein 
and the identified phosphorylation sites are shown in the top panel. The 
Akt consensus site [RERLLS*, Ser71] is present in Tmod3 but not in 
other Tmod isoforms as shown in the lower panel. (E) Akt1 and Akt2, 
interacts with Tmod3 in vitro, respectively. Immobilized GST or GST-
Tmod3 by glutathione beads was incubated with lysate of HEK293T 
expressing FLAG-Akt1 or FLAG-Akt2, respectively, for 2 hr. Bound 
proteins were subjected to SDS-PAGE and immunoblotted with anti-
FLAG Ab. The bands of GST- and GST-Tmod3 proteins captured by 
glutathione beads in Coomassie Blue stained gel are shown in the 
lower panel. Data are representative of N = 3 except (A) and (D). 
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3.1.3 Akt2 phosphorylates Tmod3 in vitro 
 
 
To determine whether Tmod3 is a direct substrate for Akt2, HA-Tmod3 
was expressed in HEK293T cells and immunoprecipitated with anti-HA 
affinity beads. Tmod3 proteins were eluted from the beads with HA 
peptide before being subjected to an in vitro kinase assay in the 
presence of constitutively active Akt2 (FLAG-Akt2-CA) and γ-32P-ATP. 
Figure 3-1-3A shows that active Akt2 does induce Tmod3 
phosphorylation, demonstrating that Tmod3 is an Akt2 substrate. In 
addition to 32P-autoradiography, using anti-phospho-Akt-substrate 
antibodies (anti-PAS) to detect phosphorylation signals, western blot 
analysis of an in vitro non-radioactive kinase assay revealed that wild-
type Tmod3 protein, but not S71A mutant, was phosphorylated, 
confirming that Ser71 is the site of phosphorylation by Akt2 (Figure 3-1-
3B). As for positive control of the assay, GSK3-fusion protein was 
phosphorylated as expected. Concordantly, Ser71 phosphorylation of 
Tmod3 was also identified in brown fat of mice from a mouse tissue-
specific atlas protein phosphorylation MS analysis by Steve Gygi's 
group (IPI00119478, (58)). Intriguingly, Ser25 phosphorylation was 
also detected in kidney, lung and spleen but not in the fat tissue. To 
address the possibility of Ser25 of Tmod3 being phosphorylated by 
Akt2, site-directed mutagenesis by converting S25 to alanine in both 
WT and S71A background was performed. As shown in Figure 3-1-3C, 
S25A mutant was phosphorylated whereas S25A/S71A double mutant 
was not, further confirming that Ser71 is the Akt2 phosphorylation site. 
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Figure 3-1-3 Tmod3 is phosphorylated by Akt2 in vitro 
(A) Akt2 phosphorylates Tmod3 in vitro. Purified full-length mouse 
Tmod3 was incubated with constitutively active Akt2 and γ-32P-ATP in 
an in vitro kinase assay. The samples were analyzed by SDS-PAGE 
and autoradiography. (B) Akt2 directly phosphorylates Tmod3 at Ser71 
in vitro. Kinase assays were performed using purified FLAG-Akt2-CA 
with either WT or S71A Tmod3 carrying HA-tag. GSK3 fusion protein 
was used as a positive control (GSK3-FP). Phospho-signals were 
detected by anti-PAS Ab (Cell Signaling). IB, immunoblot. Prefix p 
indicates phosphorylated moiety. (C) Ser71, not Ser25, is the exact 
phosphorylation target of Akt2 as demonstrated by in vitro kinase 











3.1.4 Akt2-mediated Tmod3 phosphorylation is regulated by 
insulin signaling in vivo 
 
 
To seek evidence of in vivo phosphorylation, HA-Tmod3 proteins were 
co-expressed in HEK293T cells with either constitutively active (FLAG-
Akt2-CA) or kinase inactive Akt2 (FLAG-Akt2-DN, R274H mutation 
(22)) and subjected to co-immunoprecipitation using anti-HA or anti-
FLAG affinity beads, or anti-PAS accordingly. Wild-type Tmod3 was 
phosphorylated in the presence of active Akt2 whereas S71A mutant 
was not, and this observation was confirmed by reverse-IP with anti-
PAS (Figure 3-1-4A). Furthermore, MS analysis of Tmod3 purified from 
HEK293T cells co-expressing Tmod3 and active Akt2 showed that Akt2 
specifically phosphorylated Tmod3 at Ser71, but not other serine 
residues (Figure 3-1-4B). To examine whether endogenous Tmod3 in 
3T3-L1 adipocytes could undergo phosphorylation in response to 
insulin stimulation, anti-PAS Ab was used to immune-precipitate the 
phosphorylated substrates of Akt from the lysate and the samples were 
subjected to western blotting with anti-Tmod3 Ab. Tmod3 was 
markedly phosphorylated in the cells treated with insulin. However, this 
phosphorylation was largely abolished in the cells pre-treated with PI3K 
inhibitors (LY294002, wortmannin) or Akt inhibitor 1/2 (Figure 3-1-4C-
D). These data indicate that insulin signaling mediates Tmod3 
phosphorylation in vivo.  
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Figure 3-1-4 Insulin signaling regulates Akt2-mediated 
phosphorylation of Tmod3 
 (A) Tmod3 interacts with constitutively active Akt2, but not kinase 
inactive Akt2, and becomes phosphorylated. Akt2-mediated 
phosphorylation of Tmod3 in HEK293T cells following co-expression of 
Tmod3 (WT or S71A) with either constitutively active (CA) or kinase 
inactive mutant (DN) of Akt2. (B) Identification of Ser71 residue in 
Tmod3 as the phosphorylation site of Akt2 with MS as described in 
CHAPTER II Section 2.5. (C) Insulin stimulates phosphorylation of 
endogenous Tmod3 in 3T3-L1 differentiated adipocytes. Anti-PAS was 
used to pull down phosphorylated Akt substrates from cell lysates 
followed by immunoblotting with anti-Tmod3 Ab. (D) Insulin induces 
phosphorylation of Tmod3 in a PI3K/Akt signaling dependent manner. 
3T3-L1 differentiated adipocytes were either untreated or pretreated 
with wortmannin (100 nM) or LY294002 (50 μM) or Akt 1/2 inhibitor (10 
μM) for 1 hr before insulin stimulation for 20 min. Anti-PAS Ab was 
used for immunoprecipitation of phosphorylated Akt substrates from 
cell lysates of adipocytes followed by immunoblotting with anti-Tmod3 
Ab. Data are representative of N = 2 except (B).  
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3.1.5 Insulin-stimulated phosphorylation of Tmod3 is primarily 
mediated by Akt2 in adipocytes  
 
 
Analysis for phosphorylation of ectopically expressed FLAG-tagged 
Tmod3 in insulin-stimulated adipocytes reproduced similar findings, 
therefore further establishing that phosphorylation of Tmod3 is insulin-
signaling dependent (Figure 3-1-5A). It is notable that both Akt1 and 
Akt2 isoforms are expressed in 3T3-L1 adipocytes. To address which 
isoform of Akt is primarily responsible for phosphorylation of Tmod3, 
gene silencing was performed in adipocytes using lentiviruses 
expressing shRNA against Akt1 or Akt2, respectively. As shown in 
Figure 3-1-5B, KD of Akt2 in adipocytes significantly impaired the 
phosphorylation of Tmod3. By contrast, KD of Akt1 had modest effects. 
More compellingly, expression of human Akt2, which is resistant to 
shRNA against mouse Akt2, was capable of restoring the insulin-








Figure 3-1-5 Akt2 is mainly responsible for phosphorylating 
Tmod3 in adipocytes 
(A) Confirmation of Tmod3 phosphorylation induced by insulin. 3T3-L1 
differentiated adipocytes stably expressing FLAG-Tmod3 WT or S71A 
were treated with or without 100 nM insulin for 20 min. Anti-FLAG M2 
beads were used to pull down Tmod3 from cell lysates followed by 
immunoblotting with anti-PAS Ab and re-blotting with anti-FLAG Ab. (B) 
Akt2, but not Akt1, specifically phosphorylates Tmod3 in adipocytes. 
Phosphorylation of FLAG-Tmod3 was examined in the cells in which 
Akt1 or Akt2 was knocked down by shRNA, respectively. 
Phosphorylation of Tmod3 was diminished in the absence of Akt2 and 
restored when an shRNA-resistant human Akt2 was introduced into 
























3.1.6 Insulin-stimulated phosphorylation of Tmod3 in mouse WAT 
in vivo  
 
 
To further confirm the findings, phosphorylation of Tmod3 was 
examined in mice. Briefly, C57BL/6 male mice were fasted for 4 hr and 
subjected to intraperitoneal injection with saline or insulin (1 U/kg body 
weight). After 15 minutes, mice were sacrificed and epididymal white 
adipose tissues (WAT) were homogenized. A Tmod3 antibody pre-
conjugated to protein A/G Sepharose beads was used to immune-
precipitate Tmod3 from tissue lysates and phosphorylation of Tmod3 
was detected by anti-PAS Ab. Increased Tmod3 phosphorylation was 
observed in white adipose tissues (WAT) from mice with insulin 
treatment, as compared with those from mice with saline treatment 
(Figure 3-1-6).  
Taken together, these data demonstrate that Tmod3 is primarily an 




















Figure 3-1-6 Insulin enhances Tmod3 phosphorylation within WAT 
in vivo 
Lysates from WAT of wild-type C57BL/6 mice (n = 10) with either saline 
or insulin injection were immunoprecipitated with antibody against 
Tmod3 and phosphorylation of Tmod3 was detected with anti-PAS Ab. 
Lysates for IP were immunoblotted with antibodies against Tmod3, 
phospho-Akt, and total Akt, respectively, as loading controls. 
Quantification of phosphorylated proteins to total protein levels is 
shown in the bottom panel. Data are mean ± SD, **p < 0.01 saline 















3.2 Insulin signaling modulates distribution of Tmod3 to 
membrane ruffles 
 




Having identified Tmod3 as an Akt2 substrate, the kinetics of Tmod3 
phosphorylation occurring in adipocytes was investigated by treating 
the cells with insulin at different time points. Tmod3 phosphorylation 
rapidly peaked at 5 min after insulin treatment and remained at 
moderate levels through the treatment period, in conjunction with intact 
association with phospho-Akt, as demonstrated in immunoprecipitation 
study (Figure 3-2-1A). Indeed, a subset of Tmod3 was strongly co-
localized with phospho-Akt at the cell periphery within 5 min of insulin 
stimulation (Figure 3-2-1B). Interestingly, the localization of Tmod3 to 
membrane ruffles was significantly reduced in Akt2-KD adipocytes in 
insulin-stimulated condition (Figure 3-2-1C), suggesting that Akt2 may 
play a role in directing the localization of Tmod3 to membrane ruffles 
prior to its phosphorylation. Increased physical interaction of Tmod3 
with activated Akt and their co-localization at the cell periphery in 
insulin-stimulated condition may specify a shared functional site of 
actions for these proteins, thereby permitting certain physiological 






Figure 3-2-1 Tmod3 undergoes phosphorylation and co-localizes 
with phospho-Akt in adipocytes in response to insulin stimulation 
(A) Kinetics of insulin-induced phosphorylation of Tmod3 in adipocytes. 
3T3-L1 differentiated adipocytes stably expressing FLAG-Tmod3 were 
treated with or without 10 nM insulin at different time points. 
Phosphorylation of FLAG-tagged Tmod3 was detected using anti-PAS 
Ab. (B) Differentiated adipocytes stably expressing FLAG-Tmod3 at 
day ten were serum-starved for 2 hr and treated with or without insulin 
(10 nM) for 5 min. Cells were fixed and permeabilized with 0.1% 
saponin in PBS before immunostaining with mouse anti-FLAG and 
rabbit anti-phospho-S473-Akt Abs followed by Alexa Fluor 488-
conjugated goat anti-mouse and Alexa Fluor 568-conjugated goat anti-
rabbit secondary Abs, respectively. Scale bar: 20 μm. Fluorescence 
intensity was quantified along the lines shown in the bottom panels. (C) 
Decreased presence of Tmod3 at cell periphery of Akt2 KD adipocytes 
in insulin-stimulated condition. Scale bar: 20 μm. Fluorescence 
intensity was quantified along the lines shown in the right panels. Data 







3.2.2 Tmod3 interacts with multiple phosphoinositides in vitro 
 
 
Since Tmod3 increased its presence at cell periphery of adipocytes 
and was associated with phospho-Akt upon insulin stimulation, it is 
possible that Tmod3 might be recruited to PIP3 cluster in lipid rafts and 
therefore subjected to Akt-mediated phosphorylation on the same 
functional site. Several lines of evidence from recent literature have 
supported the concept that certain actin-binding proteins are capable of 
relating phosphoinositide signaling to actin cytoskeleton. For example, 
Dictyostelium class I myosins (ID, IE and IF), which are membrane-
bound, actin based motor proteins, were identified as PIP3 effectors to 
facilitate actin remodeling during chemotaxis and phagocytosis (59). A 
comprehensive MS analysis of the phosphoinositide interactome in 
LIM1215 colon cancer cell line back in 2009 revealed that Tmod3 was 
detected in liposome incorporated with immobilized PIP3 beads 
specifically (60), further raising the likelihood of insulin-triggered 
targeting of Tmod3 to PIP3 microdomains. The binding affinities 
towards phosphoinositides for Tmod3 were first assessed using in vitro 
lipid dot blot analysis. Proteins of GST-Tmod3 and GST-PHAkt1 were 
incubated with nitrocellulose membranes carrying different 
phosphatidylinositols (Figure 3-2-2). After overnight incubation, 
membranes were washed extensively and subjected with western blot 
with anti-GST Ab. As a positive control, GST-PHAkt1 bound to PI(3,4)P2 
and PIP3 specifically as expected. By contrast, Tmod3 interacted with a 
variety of phosphoinositides under in vitro condition. 
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Figure 3-2-2 Tmod3 binds to multiple phosphoinositides in vitro 
(A) Recombinant GST-Tmod3 and GST-PHAkt1 were eluted by L-
glutathione and revealed by Coomassie Blue staining. (B) Lipid dot blot 
analysis shows Tmod3 interacted with a variety of phosphoinositides in 
vitro. LPA, lysophosphatidic acid; LPC, lyso- phosphocholine; PI, 
phosphatidy- linositol; PE, phosphatidylethanol-amine; PC, 
phosphatidylcholine; S1P, sphingosine 1-phosphate; PA, phosphatidic 





























3.2.3 Insulin signaling regulates localization of Tmod3 to PIP3-rich 
structures at the cell periphery 
 
 
As in vitro phosphoinositide specificity for Tmod3 does not necessarily 
reflect or recapitulate which particular phosphoinositide Tmod3 
preferentially interacts with in vivo, given the fact that interaction of a 
protein with any specific phosphoinositide is subjected to intracellular 
regulation at spatial, temporal and signaling-mediated conditional 
manner. To determine whether Tmod3 binds to PIP3 in cells, CHO-IR, 
a Chinese Hamster Ovary cell-line stably expressing insulin receptor, 
which displays intact insulin-responsiveness, was first transduced with 
lentiviruses encoding Tmod3-Venus and tdTomato-PHAkt1, a 
fluorescent reporter for PIP3. The localization of Tmod3-Venus was 
then observed using wide-field fluorescence microscopy in both fixed 
and live-cell conditions. As expected, Tmod3-Venus and tdTomato-
PHAkt1 were localized primarily in the cytoplasm at basal state, but were 
transiently translocated to the PIP3-specific membrane upon insulin 
stimulation. Conversely, pretreatment with the PI3K inhibitor 
wortmannin inhibited insulin-induced membrane ruffles and blocked the 













Figure 3-2-3 Tmod3-Venus translocates to PIP3-rich membrane 
(A) Tmod3 is relocated to PIP3-rich membrane in insulin-stimulated 
condition. CHO-IR cells expressing Tmod3-Venus and tdTomato-
PHAkt1, a biomarker for PIP3, were treated with or without insulin (100 
nM) for 20 min, or pre-incubated with wortmannin before insulin 
treatment. Cells were fixed and subjected to wide-field imaging. 50 
cells in total were analyzed for each group from three independent 
experiments. Representative images are shown. Scale bar: 20 μm. (B) 
CHO-IR cells expressing Tmod3-Venus and tdTomato-PHAkt1 were 
stimulated by insulin (100nM). Time-lapse images were recorded for 20 
min at an interval of 15 second. Serial images at selected time-course 
are shown. (C) Selected time-lapse series of images for wortmannin 
pre-treated cells upon insulin stimulation are shown.  
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It is well established that Akt is recruited to PIP3-specific microdomains 
and becomes activated through phosphorylation at residues of T308 
and S473, respectively. The findings of time-lapse imaging strongly 
suggest that relocation of Tmod3 to PIP3-specific membrane may be a 
prerequisite of Akt-mediated phosphorylation. Indeed, insulin 
stimulation significantly enhanced Tmod3-Venus interaction with Akt, 
which was reversed by pretreatment of wortmannin (Figure 3-2-4A). 
Notably, Tmod3 readily interacted with Akt at the basal state through its 
LRR domains as demonstrated by in vitro GST-pull down assay (Figure 
3-2-4B). GST-Tmod3 fragment (of 150-352 amino acids) pulled down 
Akt2 efficiently as comparable to GST-Tmod3 WT. By contrast, GST-
Tmod3 N-terminal fragment  (1-163 amino acids) failed to interact with 
Akt2 in vitro. Together, these results suggest that Akt2 and Tmod3 may 
translocate as a complex to PM, particularly PIP3-microdomains under 
insulin stimulation, prior to Akt2 activation and ensuing Tmod3 
phosphorylation. Therefore, Tmod3 acts not only as a direct substrate 




Figure 3-2-4 Translocation of Tmod3 to PIP3-rich membrane and 
phosphorylation in response to insulin 
(A) Enhanced interaction of Tmod3 with Akt and phosphorylation of 
Tmod3. Tmod3-Venus was pulled-down with GFP-Trap agarose beads 
(Chromotek) and the samples were subjected to western blot analysis. 
(B) Direct binding of Tmod3 to Akt2 requires LRR domains. Proteins of 
GST-Tmod3 full-length and different fragments were purified by 
glutathione beads from bacteria and incubated with HEK293T lysate 
expressing FLAG-Akt2-WT for 2 hr. Pulled-down samples were 
subjected to immunoblotting with anti-FLAG Ab. Data are 




















3.3 Importance of Tmod3 in regulating insulin-stimulated glucose 
transport and GLUT4 translocation 
 
3.3.1 Tmod3 clusters around cortical F-actin and co-localizes with 
GLUT4 at insulin-induced membrane ruffles 
 
 
Tropomodulin proteins block the elongation and depolymerization of 
the pointed end of actin filaments and therefore contribute to the 
geometry of the membrane cytoskeleton (56). Tmod3 has been 
previously shown to localize preferentially to the F-actin-rich structures 
at the cell periphery, including lamellipodia and ruffles (61). As shown 
in Figure 3-3-1A, Tmod3 at the cell periphery was associated with 
phalloidin-labeled cortical F-actin at the sites of insulin-induced 
membrane ruffles, and co-localized with GLUT4 (Figure 3-3-1B). Given 
the importance of Akt signaling and cortical actin remodeling in 
regulating GSV translocation, it is conceivable that Tmod3 may be 
involved in the regulation of insulin-stimulated GLUT4 translocation and 









Figure 3-3-1 Tmod3 increases its appearance at insulin-induced 
membrane ruffles and is associated with cortical F-actin and 
GLUT4 in adipocytes 
(A) Cells were immunostained for FLAG-Tmod3 (green) and actin 
filaments were labeled with Alexa Fluor-568-Phalloidin (red). The side 
panels show enlarged views of the boxed regions. Fluorescence 
intensity was quantified along the lines shown in the bottom panels. 
Scale bar: 20 μm. (B) Co-localization of FLAG-Tmod3 and GLUT4-
mCherry at the periphery in adipocytes in response to insulin 
stimulation. Fluorescence intensity was quantified along the lines 
shown in the bottom panels. Scale bar: 20 μm. Data are representative 
of N = 2.  
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3.3.2 Tmod3 functions downstream of Akt signaling and is 
required for insulin-stimulated glucose transport 
 
 
To investigate the roles of Tmod3 on glucose uptake, a lentiviral 
construct encoding shRNA against Tmod3 was generated in order to 
deplete the endogenous target proteins in adipocytes. In Tmod3-KD 
3T3-L1 adipocytes, proximal insulin signaling remained intact and was 
not altered, as compared with the control cells, suggesting that Tmod3 
functions downstream of Akt signaling and has no effect on the 
upstream insulin signaling cascade (Figure 3-3-2A). A 2-deoxyglucose-
uptake assay was then conducted to examine whether loss of Tmod3 
would affect insulin-stimulated glucose transport in adipocytes. As 
shown in Figure 3-3-2B, insulin induced glucose uptake significantly in 
adipocytes as compared to control treatment. On the contrary, Tmod3 
KD cells displayed a ~30% reduction in insulin-stimulated glucose 














Figure 3-3-2 Tmod3 functions downstream of Akt signaling and is 
required for insulin-stimulated glucose transport  
(A) Knockdown of Tmod3 has no or little effect on proximal insulin 
signaling. 3T3-L1 differentiated adipocytes at day four were infected 
with lentivirus carrying the shRNA against Tmod3 (shTmod3) or the 
scrambled shRNA (scr) for 48 hr, and then replaced with fresh media 
and maintained until day ten. Cells were serum-starved for 2 hr, treated 
with or without insulin (100 nM) for 20 min and harvested for western 
blot analysis. (B) Silencing of Tmod3 impairs glucose transport in 
adipocytes. Cells were serum-starved for 3 hr, and treated with or 
without insulin (100 nM) for 20 min for 2-deoxyglucose-uptake assay. 
Data are mean ± SEM of four independent experiments. **p < 0.01 




























Since insulin-induced glucose transport is primarily mediated by 
GLUT4 translocation in adipocytes, GLUT4 exocytic pathway may be 
disrupted due to the loss of Tmod3. A lentiviral construct was 
generated to express a Myc-GLUT4-mCherry fusion protein in which 
the Myc epitope was inserted in the first exofacial loop of GLUT4 N 
terminus, and mCherry fused at the C terminus (Figure 3-3-3A), 
therefore allowing the detection of GLUT4 upon PM insertion (by Myc 
in non-permeabilized condition) and of total GLUT4 content (by 
mCherry), similar to the constructs previously reported by others (62, 
63). GLUT4 translocation is quantified by measuring the Myc signal 
detected by anti-Myc antibody/anti-mouse-AlexaFluor 488 over the 
mCherry fluorescent intensity for individuals cells by confocal imaging, 
and is presented as percentage of Myc-GLUT4-mCherry at PM. In 
control cells, 10 nM insulin induced approximately 55% of GLUT4 
presence at the cell surface while silencing of Tmod3 in adipocytes 
significantly reduced the GLUT4 presence to ~20% (Figure 3-3-3B and 
C). These results indicate that Tmod3 is necessary for insulin-
stimulated glucose transport and GLUT4 translocation in adipocytes. 
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Figure 3-3-3 Tmod3 is necessary for insulin-stimulated GLUT4 
exocytosis 
(A) GLUT4 fusion protein for detection of GLUT4 translocation and PM 
surface exposure. (B-C) Knockdown of Tmod3 inhibits insulin-
stimulated GLUT4 translocation. Infected adipocytes at day ten were 
serum starved for 2 hr and treated with or without insulin (10 nM) for 20 
min. Upon fixation, cell surface Myc-GLUT4-mCherry was detected 
with anti-Myc mouse monoclonal Ab followed by Alexa Fluor 488-
labeled goat anti-mouse secondary Ab in non-permeabilized cells. 
Samples were subjected to confocal microscopic imaging. Percentage 
of Myc-GLUT4-mCherry at plasma membrane of individual cells was 
quantified as 100 x Fmyc-PM/FmCherry-Total. Data are presented as mean ± 
SEM of ~100 cells in each group from three independent experiments. 
**p < 0.01 versus scr + Ins group. Representative images are shown in 



















3.3.4 Dissecting the site of action for Tmod3 in GLUT4 
translocation using TIRFM  
 
 
By examining carefully the distribution of Myc-GLUT4-mCherry in 
Tmod3-KD adipocytes, substantial amount of GLUT4 accumulated at 
the cell periphery as revealed by mCherry fluorescent signals, and yet 
the cells showed weak green fluorescent signals, suggesting that 
silencing of Tmod3 results in impairment of GLUT4 vesicle fusion 
without affecting the mobilization of GSVs from the intracellular storage 
compartment (Figure 3-3-3C). To ascertain this phenomenon, total 
internal reflection fluorescence microscopy (TIRFM) was applied in 
order to restrict the field of view to only ~200 nm from the PM and the 
distribution of Myc-GLUT4-mCherry was examined under non-
permeabilized condition in the fixed cells. Ratio of TIRF-Myc 
fluorescence to Epi-mCherry fluorescence is used as an indicator of 
GLUT4 insertion. As shown in Figure 3-3-4A, insulin-stimulated control 
cells exhibited intense GLUT4 translocation as illuminated by bright red 
and green fluorescent intensities in the TIRF zone as expected. For 
validation of this approach, Akt2-KD adipocytes were used as negative 
control, displaying a significant reduction of GLUT4 at the cell periphery 
as shown by concomitant loss of both red and green fluorescent 
signals, in agreement with essential roles of Akt2 to both steps of distal 
trafficking and vesicle fusion in GLUT4 translocation (19). By contrast, 
disruption of cortical actin in adipocytes with Latrunculin B treatment 
caused accumulation of GSVs in the TIRF zone, but significantly 
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impaired GLUT4 vesicle fusion (Figure 3-3-4B-C). Using TIRFM-based 
approach, the potential roles for Tmod3 on the intermediate steps of 











































Figure 3-3-4 Impaired GLUT4 translocation in adipocytes upon 
Akt2 knockdown or Latrunculin B treatment under TIRFM 
(A) Both TIRF-mCherry and TIRF-Myc signals were detected in insulin-
stimulated control cells in TIRF zone, indicating proper GLUT4 
translocation and fusion with PM. As for negative control, TIRF signals 
were significantly decreased in Akt2-deficient adipocytes. Scale bar: 20 
μm. (B-C) Latrunculin B inhibits vesicle fusion but not trafficking of 
GLUT4 to the cell periphery. Data are shown as the ratio of cell surface 
TIRF-Myc signal to total Epi-mCherry and presented as mean ± SD of 
~ 30 cells in each group. ***p < 0.001 versus mock + Ins group. 










3.3.5 Tmod3 is required for GLUT4 insertion into the PM but not 
the trafficking of GSVs to the periphery 
 
 
Intriguingly, KD of Tmod3 did not block the movement of GLUT4 to the 
cortical area but caused a significant reduction of GLUT4 insertion, 
indicated by the remaining intact red fluorescence and relatively weak 
green fluorescence (Figure 3-3-5B: scr + Ins [5.78 ± 0.33] versus 
shTmod3 + Ins [1.65 ± 0.11]). As for negative control for the 
experiment, another batch of cells permeabilized with saponin before 
immunostaining with anti-Myc Ab showed both red and green 
fluorescence in the TIRF zone. The observation in intact Tmod3 KD 
cells is somewhat similar to the situation whereby the adipocytes 
disrupted of cortical actin by Latrunculin B treatment displayed low 
activities of GLUT4 fusion (Figure 3-3-4C, (41)). 
Taken together, these findings suggest that Tmod3 is specifically 
required for GSV fusion with the PM, but not its mobilization and 















Figure 3-3-5 Tmod3 is required for vesicle fusion but not 
trafficking 
(A) Schematic drawing illustrating events observed under total internal 
reflection fluorescence imaging zone (TIRF zone). (B-C) Knockdown of 
Tmod3 impairs GLUT4 vesicle fusion with PM. Insulin-induced insertion 
of GLUT4 into PM was examined using TIRF microscopy in non-
permeabilized cells. Data are shown as the ratio of cell surface TIRF-
Myc signal to total Epi-mCherry and presented as mean ± SEM of ~50 
cells in each group from three independent experiments. **p < 0.01 
versus scr + Ins group. Representative microscopic images for both 











3.4 Roles of Tmod3 phosphorylation in insulin-stimulated glucose 
transport and GLUT4 translocation 
 




In light of previous studies that supported Akt2 as a key hub of insulin 
signaling cascade by regulating multiple downstream factors of GLUT4 
translocation through phosphorylation (64), Akt2-dependent Tmod3 
phosphorylation may be an important step for GLUT4 exocytosis. 
Having demonstrated that Akt2 phosphorylates Tmod3 at Ser71, the 
next reasonable move is to examine the effects of phosphorylation 
mutants of Tmod3 on insulin-stimulated glucose transport and GLUT4 
translocation. Lentiviral constructs (Tmod3-RRs) expressing shRNA-
resistant WT or variants of Tmod3 were generated. Ectopic lentiviral 
expression of these Tmod3 mutants was successfully achieved in the 
adipocytes in which the endogenous Tmod3 was silenced, in an effort 
to specifically address the importance of Tmod3 phosphorylation by 
eliminating the effects of endogenous Tmod3 (Figure 3-4-1A). As 
shown in Figure 3-4-1B, expression of a phospho-defective mutant 
(S71A) was inhibitory to insulin-stimulated glucose transport whereas 
expression of phospho-mimetic mutant (S71D) resulted in increased 
capacity of glucose uptake. Interestingly, mutation at L73 (L73D), which 
disrupts the second α-helix of Tmod3 and decreases both its actin 
monomer–binding and –nucleating activities (52), elicited a similar 
effect as that seen for S71D mutation. 
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Figure 3-4-1 Effects of Tmod3 phosphorylation on insulin-
stimulated glucose transport in adipocytes 
(A) Western blots show the expression levels of endogenous Tmod3 
and FLAG-tagged Tmod3 variants in adipocytes detected by anti-
Tmod3 and anti-FLAG Abs. Tubulin was used as loading control. (B) 
Ectopic expression of different variants of Tmod3 elicits distinct effects 
on glucose transport in adipocytes. Cells were serum-starved for 3 hr, 
and treated with or without insulin (100 nM) for 20 min for the 2-
deoxyglucose-uptake assay. Data are mean ± SEM of four 





















Results of insulin-induced glucose transport support the notion that 
Tmod3 phosphorylation may play a positive role in driving GLUT4 
exocytosis. Therefore, a TIRFM-based Myc-GLUT4-mCherry assay 
was conducted in order to evaluate the effects of different variants of 
Tmod3 on insulin-stimulated GLUT4 exocytosis in adipocytes. In 
insulin-stimulated condition, cells expressing phospho-defective 
Tmod3-S71A Tmod3 showed significantly lower surface presence of 
GLUT4 when compared with the cells expressing WT Tmod3 (Figure 3-
4-2A: WT + Ins [6.49 ± 0.21] versus S71A + Ins [2.81 ± 0.12]). On the 
other hand, cells expressing either S71D or L73D showed further 
enhancement of insulin-induced GLUT4 exocytosis (Figure 3-4-2A: 
S71D + Ins [8.99 ± 0.40]; L73D + Ins [8.47 ± 0.34]). 
Collectively, these results indicate that Tmod3 phosphorylation 
positively regulates insulin-stimulated GSV fusion with the PM, the final 















Figure 3-4-2 Effects of Tmod3 phosphorylation on insulin-
stimulated GLUT4 translocation in adipocytes 
(A-B) Phospho-defective mutant S71A inhibits, and phospho-mimetic 
mutant S71D potentiates GLUT4 vesicle fusion with PM. Insulin-
induced GLUT4 insertion was examined by TIRF-based Myc-GLUT4-
mCherry assay. Data are shown as the ratio of cell surface TIRF-Myc 
signal to total Epi-mCherry and presented as mean ± SEM of ~100 
cells in each group from three independent experiments. **p < 0.01 
versus WT + Ins group. Representative images for Tmod3 variants are 










3.5 Phosphorylation of Tmod3 regulates insulin-induced actin 
remodeling  
 
3.5.1 Phosphorylation of Tmod3 regulates its binding to 
monomeric G-actin and nucleation of actin assembly 
 
 
The evidence so far suggests that Tmod3 phosphorylation is 
functionally related to insulin-stimulated GLUT4 translocation. How 
exactly the phosphorylation of Ser71 in Tmod3 could affect its function 
from the perspective of actin remodeling remains to be elusive. One of 
the common features for actin-binding proteins is the ability of binding 
to monomeric G-actin (65). Tmod3 possesses several functional 
domains: an N terminal domain inclusive of three α-helices, five 
leucine-rich repeat (LRR) domains in the middle, and a C terminal 
domain capable of binding to F-actin filaments directly. Within the N 
terminal domain, α-helix-1 and α-helix-3 are necessary for interacting 
with tropomyosin (Tm) partner while α-helix-2 is important for G-actin-
binding and Tm-dependent actin capping (52, 66, 67). The ability of 
Tmod3 phosphorylation mutant proteins to bind G-actin was tested by 
performing in vitro actin-crosslinking assay with the zero-length cross-
linker, EDC/sulfo-NHS, followed by SDS-PAGE and immunoblotting 
(Figure 3-5-1A). Consistent with previous reports (52, 66), wild-type 
Tmod3, when mixed with G-actin, readily formed a complex with 
apparent molecular mass of 80~160 kDa, as detected by anti-actin 
immunoblot. The complex forming activity was further profound for 
phospho-defective mutant S71A. By contrast, phospho-mimetic mutant 
 71 
S71D significantly decreased the formation of the actin-Tmod3 
complex, similar to L73D. To further confirm the observation, GST-
Tmod3 WT proteins that remained bound to glutathione beads were 
subjected to in vitro kinase assay in the presence or absence of 
constitutively active Akt2. The non-phosphorylated and phosphorylated 
forms of GST-Tmod3-WT-glutathione beads were subsequently 
subjected to actin crosslinking assays. Similar to S71D mutant, the 
complex forming activity for phosphorylated Tmod3 was significantly 
reduced (Figure 3-5-1B). Together, these data suggest that Tmod3 
phosphorylation regulates its binding to monomeric G-actin and 























Figure 3-5-1 Tmod3 phosphorylation is critical for binding to 
monomeric G-actin and nucleation of actin assembly 
(A) Recombinant Tmod3 proteins were prepared and visualized by 
Coomassie Blue staining and confirmed by western blotting using anti-
Tmod3 Ab. Recombinant proteins of Tmod3 variants were mixed with 
or without G-actin at equal molar ratio and treated with EDC/sulfo-NHS 
crosslinkers for 45 min at RT. Reactions were terminated by adding 2X 
SDS sample buffer followed by SDS-PAGE and western blotting using 
antibody against actin. The bottom right panel shows the western blot 
of Tmod3 proteins in actin crosslinking assay. (B) GST-Tmod3 wild-
type proteins were purified from bacteria by glutathione beads pull-
down and subjected to in vitro kinase assay in the presence or 
absence of purified constitutively active Akt2, followed by actin 
crosslinking assay, as described in the schematic diagram on the 




3.5.2 Phosphorylation of Tmod3 regulates insulin-induced cortical 
actin remodeling in vivo 
 
 
To investigate whether phosphorylation of Tmod3 could influence the 
activities of insulin-induced cortical actin remodeling in vivo, CHO-IR 
cells were infected with lentivirus encoding Lifeact-tdTomato, a peptide 
fused with tdTomato red fluorescent protein capable of binding to F-
actin without affecting its function, similar to Lifeact-GFP as previously 
described (Figure 3-5-2A, (49)). As compared to basal condition, 
insulin stimulation led to continuously increased F-actin structures as 
shown by increased Lifeact-Tdtomato fluorescence under TIRFM 
(Figure 3-5-2B-D). This rapid remodeling of F-actin in the immediate 
vicinity of the PM was inhibited by pretreatment with wortmannin. As for 
control, Latrunculin B treatment induced an overwhelming collapse of 
actin in TIRF zone. Overexpression of S71A mutant reduced the 
insulin-induced actin reorganization, whereas overexpression of S71D 
mutant enhanced the actin remodeling, along with increased 
membrane reorganization (Figure 3-5-2E-G). Taken together, Tmod3 








Figure 3-5-2 Phosphorylation of Tmod3 enhances insulin-induced 
actin remodeling in vivo 
(A) CHO-IR cells stably expressing Lifeact-tdTomato were imaged by 
TIRF microscopy. Representative images for both Epi- and TIRF-
microscopy are shown. Scale bar: 20 μm. (B) The mean time course of 
TIRF-tdTomato under different conditions are shown (n = 10 cells per 
condition). (C) Quantification of the area under curve (AUC) in Lifeact-
tdTomato fluorescence intensity as a percentage of control (mock 
treatment). *p < 0.05; **p < 0.01. (D) Selected time-lapse images of 
actin remodeling in cells expressing Lifeact-tdTomato under different 
conditions. Scale bar: 20 μm. (E) The mean time course of TIRF-
tdTomato in cells expressing Tmod3 variants are shown (n = 10 cells 
per condition). (F) Quantification of the area under curve (AUC) in 
Lifeact-tdTomato fluorescence intensity as a percentage of control 
(WT-Ctrl). *p < 0.05 or **p < 0.01. (G) Selected time-lapse images of 
actin remodeling in cells co-expressing Lifeact-tdTomato and Tmod3 








3.6 Identification of cognate Tropomyosin partner for Tmod3 in 
adipocytes 
 




Tropomodulin proteins bind specifically to the pointed end of the actin 
filament and control actin polymerization by regulating the stability, 
lengths, and architecture of actin filaments. However, the binding 
affinity of tropomodulin to actin filaments is modest at the basal state 
(Kd ~ 0.3-0.4 μM) but can be dramatically enhanced (Kd ~ 50 pM) in 
the presence of Tm (68). The interaction between Tmod and Tm is 
important in regulating actin pointed-end capping activity of all Tmods. 
Moreover, the pairing of Tmod-Tm isoform is selective, with different 
combinations of Tmod3 and Tm isoforms having distinct binding 
preferences and affinities, depending on the expression patterns, cell 
type, and developmental stages (56). Hence, identifying the cognate 
Tm-binding partner for Tmod3 in adipocytes may gain a better 
understanding of the functional aspects of Tmod3 in the context of 
glucose transport and GLUT4 translocation. In 3T3-L1 adipocytes, 
endogenous proteins of Tm1, Tm3, Tm4 and Tm5NM1 were present as 
detected by western blotting using respective antibodies (generous 
gifts from Peter W.Gunning, Figure 3-6-1A). FLAG-tagged wild-type 
Tmod3 stably expressed in adipocytes treated with different conditions 
as indicated was immunoprecipitated using anti-FLAG M2 beads and 
then immunoblotted using the antibodies against different isoforms of 
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Tm, respectively. It turned out that Tm5NM1, the shorter form of γTm, 
was the only Tm isoform bound to Tmod3, in contrast to Tm1, Tm3 and 
Tm4 proteins, which were not detected in the immunoprecipitated 
complex from adipocytes (Figure 3-6-1A). To delineate the localization 
of Tmod3: Tm5NM1 complex, immunostaining studies were performed 
in the cells treated with similar treatments. Co-localization of Tmod3 
and Tm5NM1 was readily detected at the intracellular space under 
basal condition, and they both became concentrated at the cell 
periphery in response to insulin stimulation, which was suppressed by 
wortmannin preincubation (Figure 3-6-1B), suggesting that insulin-
induced phosphorylation may promote Tmod3-Tm5NM1 interaction. To 
test this notion, the distribution of Tmod3 and Tm5NM1 in the PM 
fractions of cells was analyzed. The PM fractions were permeabilized 
with 1% of Triton X-100 and subjected to immunoprecipitation. As 
shown in Figure 3-6-1C, Tmod3 became accumulated in the PM 
fraction and exhibited increased binding to Tm5NM1 under insulin 
stimulation, when compared with mock treatment or with wortmannin 
preincubation in adipocytes. Collectively, these data indicate that 
Tmod3 phosphorylation enhances its interaction with Tm5NM1 under 




Figure 3-6-1 Tm5NM1 is the cognate tropomyosin partner for 
Tmod3 in adipocytes 
(A) 3T3-L1 adipocytes expressing FLAG-Tmod3 were serum-starved 
for 2 hr and treated with or without insulin (10 nM) for 20 min, or 
pretreated with wortmannin (100 nM) for 30 min before insulin 
stimulation. Tmod3 immunoprecipitates were evaluated by western 
blots for identifying the specific Tm isoform interacting with Tmod3.  A 
non-specific mouse IgG Ab was used as control antibody for 
immunoprecipitation. (B) Differentiated adipocytes co-expressing 
FLAG-Tmod3 and Myc-Tm5NM1 were serum-starved for 2 hr and 
treated with or without insulin (10 nM) for 5 min, or pre-incubated with 
wortmannin. Cells were fixed and permeabilized with 0.1% saponin in 
PBS before immunostaining with mouse anti-FLAG and rabbit anti-Myc 
Ab followed by Alexa Fluor 488-conjugated goat anti-mouse and Alexa 
Fluor 568-conjugated goat anti-rabbit secondary Abs, respectively. 
Scale bar: 20 μm. Fluorescence intensity was quantified along the lines 
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shown in the bottom panels. (C) Cells co-expressing FLAG-Tmod3 and 
Myc-Tm5NM1 were treated similarly in (B) and subjected to PM 
fractionation. Elevated level of Tmod3 in insulin-treated PM fraction 
was detected by anti-FLAG-IP; correspondingly, the amount of 
Tm5NM1 that co-immunoprecipitated with Tmod3 increased with 
insulin stimulation, and wortmannin attenuated the stimulatory effect. 
As for treatment control, increased presence of IRAP level and Akt 
activation in PM fraction under insulin-stimulated condition was 








































3.6.2 Tmod3 phosphorylation regulates its binding to Tm5NM1 
 
 
Next, the indication for Tmod3 phosphorylation to affect its interaction 
with Tm5NM1 was further demonstrated in CHO-IR cells expressing 
FLAG-Tmod3 and Myc-Tm5NM1 by immunoprecipitation studies 
(Figure 3-6-2A). Moreover, using GST-tagged Tm5NM1 glutathione 
beads as baits, phosphorylated Tmod3 proteins were pulled down 
more efficiently than non-phosphorylated Tmod3 (Figure 3-6-2B). In 
another experiment, the phospho-mimetic Tmod3-S71D and L73D 
showed stronger binding, while phospho-defective Tmod3-S71A 
exhibited weaker binding with Tm5NM1 than wild-type Tmod3. As for 
negative control of GST-pull-down assay, both L29G and L134D 
mutants, which eliminate Tm-binding of the α-helix-1 and α-helix-3, 
respectively, abrogated the binding to Tm5NM1 to a greater extent 
(Figure 3-6-2C). This observation was further confirmed by reciprocal 
immunoprecipitation experiments using HEK293T cells co-expressing 
Tmod3 variants and Tm5NM1 (Figure 3-6-2D). These results 
demonstrate that Tmod3 phosphorylation enhances its binding to 










Figure 3-6-2 Phosphorylation of Tmod3 modulates its binding to 
Tm5NM1 
(A) CHO-IR cells expressing FLAG-Tmod3 and Myc-Tm5NM1 were 
serum-starved for 2 hr before treatments. Whole cell lysate was used 
for co-IP with anti-FLAG or anti-Myc Abs. (B) HEK293T cells were 
transfected with HA-Tmod3 WT plasmid alone, or in combination with 
FLAG-Akt2-CA or FLAG-Akt2-DN construct. In vitro binding assay was 
conducted by incubating GST-Tm5NM1 or GST-bound glutathione 
beads with equal amount of cell lysates for 1 hr. The beads were 
washed thoroughly and re-suspended in sample buffer followed by 
SDS-PAGE and western blot analysis. (C) GST-Tmod3 variants bound 
glutathione beads were used as baits to capture Tm5NM1 from the 
lysates of HEK293T cells expressing Myc-Tm5NM1. The phospho-
mimic S71D mutant has a stronger binding to Tm5NM1 whereas 
phospho-defective S71A mutant reduces the interaction with Tm5NM1. 
(D) HEK293T cells were transfected with the indicated plasmids. 
Tmod3 proteins were immunoprecipitated with anti-HA and probed for 
Tm5NM1 and Tmod3. Conversely, Tm5NM1 proteins were pulled-down 
with anti-Myc and probed for Tmod3 and Tm5NM1. The input panels 
show the expression levels of HA-Tmod3 and Myc-Tm5NM1 in the cell 
lysates. Data are representative of N = 3.  
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3.7 Tmod3: Tm5NM1 partnership is essential to insulin-stimulated 
glucose transport and GLUT4 translocation 
 




To address the functional relevance of Tmod3 interaction with 
Tm5NM1, a double mutant L29G/L134D of Tmod3 (equivalent to 
L27E/I131D in Tmod1, (69)) was generated and completely lost binding 
to Tm5NM1(Figure 3-7-1A). In adipocytes, the double mutant Tmod3-
L29G/L134D showed significantly reduced interaction with endogenous 
Tm5NM1 (Figure 3-7-1B). Furthermore, Tmod3-L29G/L134D retained 
insulin- and Akt2-induced phosphorylation (Figure 3-7-1B-C). These 
findings suggest that Tmod3 phosphorylation is not affected by, but 




Figure 3-7-1 Interaction of Tmod3 with Tm5NM1 does not regulate 
phosphorylation of Tmod3 
(A) Confirmation of the loss of Tm5NM1 binding for L29G/L134D 
mutant by in vitro GST-pull down assay. GST-Tm5NM1 bound 
glutathione beads were incubated with lysate of HEK293T cells 
expressing WT or L29G/L134D Tmod3 for 1 hr, washed extensively 
and re-suspended in sample buffer followed by SDS-PAGE and 
western blot analysis. (B) Impaired binding to Tm5NM1 for 
L29G/L134D mutant in adipocytes.   3T3-L1 differentiated adipocytes 
stably expressing FLAG-Tmod3 WT or L29G/L134D were treated with 
or without 100 nM insulin for 20 min. Anti-FLAG M2 beads were used 
to pull down Tmod3 from cell lysates followed by western blot analysis. 
(C) Tm-binding defective mutant of Tmod3 remains sensitive to Akt2-
mediated phosphorylation in vitro.  Immuno-purified HA-tagged wild-
type Tmod3 or L29G/L134D mutant was incubated with constitutively 
active Akt2 in a kinase reaction. Samples were subjected to SDS-








3.7.2 Tm5NM1-binding defective mutant of Tmod3 inhibits insulin-
stimulated GLUT4 translocation and glucose transport 
 
 
The significance of Tmod3 interaction with Tm5NM1 on insulin-
regulated GLUT4 translocation and glucose transport was then 
evaluated. As shown in Figure 3-7-2, ectopic expression of 
L29G/L134D mutant in adipocytes inhibited insulin-regulated GLUT4 
translocation (Figure 3-7-2A: WT+ Ins [6.20 ± 0.19] versus 
L29G/L134D + Ins [3.32 ± 0.10]) and resulted in impairment of glucose 
uptake (Figure 3-7-2C: WT + Ins [4.11 ± 0.1] versus L29G/L134D + Ins 
[2.94 ± 0.15]). Taken together, these data suggest the interaction of 
Tmod3 with Tm5NM1, which can be regulated by Tmod3 

























Figure 3-7-2 Disruption of Tmod3:Tm5NM1 complex impairs 
insulin-stimulated GLUT4 translocation and glucose transport 
(A-B) Loss of Tm5NM1-binding in Tmod3 impairs GLUT4 exocytosis. 
Insulin-induced GLUT4 insertion was examined by TIRF-based Myc-
GLUT4-mCherry assay. Data are shown as the ratio of cell surface 
TIRF-Myc signal to total Epi-mCherry and presented as mean ± SEM of 
~100 cells in each group from three independent experiments. **p < 
0.01 versus WT + Ins group. Representative images are shown in (B). 
Scale bar: 20 μm. (C) Ectopic expression of L29G/L134D mutant 
inhibits insulin-stimulated glucose uptake in adipocytes. Cells were 
serum-starved for 3 hr, and treated with or without insulin (100 nM) for 
20 min for the 2-deoxyglucose-uptake assay. Data are mean ± SEM of 





CHAPTER IV DISCUSSION 




Akt2-driven GLUT4 translocation in response to insulin signaling 
serves as a primary mechanism of glucose disposal at physiological 
condition, particularly, by skeletal muscle and adipose tissues (4). 
Latest trend in this field emphasizes the identification of Akt substrates 
which mediate the exocytosis process, in an effort to complete the 
GLUT4 circuitry and advance our understanding of glucose transport 
regulation and, more importantly, to enable us to pinpoint the major 
nodes of molecular mechanisms underlying this process that are 
responsible for impaired glucose uptake in insulin resistance. Recent 
discovery of CDP138 as a new Akt substrate involved in GLUT4 
vesicle fusion (34) has provided further indication of the absolute 
requirement of Akt2 for the fusion of GLUT4 vesicles with the PM by 
regulating the functional activities of its downstream effectors through 
phosphorylation in this final step of exocytosis. Although the 
mechanisms that regulate membrane fusion of GLUT4 are not 
completely understood, it is becoming clear that cortical actin 
remodeling plays a pivotal role, in coordination with SNARE machinery, 
small GTPases, and their associated regulators and effectors, to bridge 
and eventually merge the two lipid bilayers between vesicle and 
plasma membrane, thus allowing the insertion of GLUT4 proteins into 
the cell surface and therefore glucose transport (2).  
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Earlier study provided the indication that cortical actin remodeling 
is necessary for insulin-stimulated GLUT4 translocation and glucose 
uptake in adipocytes (70). The idea that proposes the dynamic cortical 
actin rearrangement, but not static actin barrier, is functionally required 
for GLUT4 vesicle incorporation into the PM, has been demonstrated in 
adipocytes as well as in muscle cells (71). With regard to mechanisms 
underlying insulin-induced actin rearrangement, study of Jiang et al. 
revealed that insulin-mediated actin rearrangement in adipocytes is 
insensitive to the PI3K inhibitor wortmannin (72). The involvement of N-
WASP, Arp2/3, TC10, and Myo1c has been proposed to function as 
downstream of PI3K-independent insulin signaling pathway to mediate 
the actin rearrangement in preparation for GLUT4 exocytosis (42, 45, 
73). On the other hand, MyosinVa, a non-muscle-type F-actin-
interacting motor protein, was identified to be an insulin-stimulated Akt2 
substrate involved in anterograde GLUT4 vesicle trafficking in 3T3-L1 
adipocytes (46). Meanwhile, a cardiomyopathy-associated F-actin 
binding protein called Nexilin was shown to interact with IRS1 to 
regulate insulin-stimulated glucose transport in skeletal muscle cells. 
Nexilin was proposed to confine IRS-1 to actin-rich structures in basal 
condition and insulin-elicited dissociation of this complex may increase 
the efficiency of IRS-1/PI3K interaction and PIP3 production at localized 
sites (74). Furthermore, in the field of carcinogenesis, palladin, an 
actin-bundling protein, was identified as an Akt1-specific substrate 
regulating IGF-1 or EGF-induced breast cancer cell motility (75). 
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Despite the mechanisms regulating insulin-induced actin remodeling 
are not completely understood, literature so far seems to suggest the 
co-existence of PI3K-dependent and PI3K-independent pathways, both 
of which may work in parallel and possibly converge at some point, in 
mediating the functional activities of different actin-binding proteins 
during exocytosis. Relating to the importance of membrane actin to the 
pathogenesis of insulin resistance and diabetes, previous reports have 
shown that PM PIP2 and cortical F-actin structure are reduced in both 
3T3-L1 adipocytes and L6 myotubes with chronic insulin or high 
glucose treatment, leading to impairment of insulin-stimulated GLUT4 
translocation and glucose transport (71, 76). Interestingly, high-fat-diet-
fed insulin-resistant mice show elevated levels of membrane 
cholesterol and reduced F-actin structure in skeletal muscle compared 
with normal chow-fed mice (77). 
 
 
4.2 Significance of current study 
 
 
Current study highlights the significance of cortical actin remodeling as 
a critical node of molecular machinery underlying insulin-stimulated 
GSV fusion, consistent with the hypothesis that Tmod3 is a 
downstream target of Akt2 mediating this process. Tmod3 is an Akt2-
interacting partner and substrate in adipocytes. In the basal state, 
Tmod3 readily associates with Akt2 through its well-conserved LRR 
domains at the C-terminus. In response to insulin activation, PIP2, the 
most abundant phosphoinositide, serves as a substrate for PI3K in the 
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synthesis of PIP3, which is a key messenger in propagating the signals 
from insulin receptor to GSVs. Both Akt2 and Tmod3 are relocated to 
PIP3-membrane clusters where Akt2 is activated and in turn 
phosphorylates Tmod3, as evidenced by increased interaction and co-
localization between Akt and Tmod3 at membrane ruffles in insulin-
stimulated condition. The observation of PIP3-involvement in clustering 
these two proteins provides a logical explanation for delineating the 
relationship between Akt2 (as a kinase) and Tmod3 (as a substrate) 
and the functional site of actions for phosphorylated form of Tmod3. 
The findings in this study demonstrate a functional role for Tmod3 in 
insulin-stimulated GLUT4 translocation and glucose uptake, particularly 
at the step of vesicle fusion, as revealed in TIRFM study, which shows 
that depletion of Tmod3 inhibits GSV-PM fusion, but not the trafficking 
of GSV to the cortical area. Under insulin stimulation, PIP3-clustering 
facilitates Akt2-mediated phosphorylation of Tmod3, and 
phosphorylated Tmod3 in turn alters its interaction with monomeric 
actin to effect cortical actin rearrangement, and promotes GSV fusion 
and GLUT4 surface exposure. 
The identification of Tmod3 as a downstream target for Akt 
phosphorylation also provides a mechanism by which insulin can 
specify the assembly of actin filaments with specific functional 
properties. Tropomodulins, encoded by four genes in mammals, 
primarily function by binding to the pointed end of actin filaments (56). 
This binding slows the rate of turnover of actin filaments because actin 
is mostly lost from the pointed end of the filament and tropomodulin 
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inhibits this loss (56). Tropomodulin binds to both the actin at the 
pointed end and also to the tropomyosin, which forms a co-polymer 
along the length of the actin filament (78). There are over 40 
tropomyosins and the tropomodulins show a preference for binding to 
specific types of tropomyosin (79). It is this interaction with tropomyosin 
and preference for isotype, which is likely to link the phosphorylation of 
Tmod3 to the formation of a specific type of actin filament in the 
submembranous region. 
Actin filaments can be considered to be composed of two broad 
classes, those that consist of just the two stranded actin polymer and 
those that consist of a co-polymer of both actin and tropomyosin (79). 
Many tropomyosin isoforms and cytoskeletal actin filaments are largely, 
if not entirely, composed of homo-polymers of specific tropomyosin 
dimers. This provides a structural homogeneity to the filament. The 
type of tropomyosin dimer bound to the actin filament determines the 
functional capacity of the filament by regulating the nature of its 
interactions with actin binding proteins and myosin motors (79-81). In 
the case of adipocytes, Tmod3 shows a very clear preference for 
binding to actin filaments containing the tropomyosin, Tm5NM1/2. The 
pull-down experiments show that the other tropomyosin isoforms in the 
cell are not associated with Tmod3. 
The binding of Tmod3 to actin filaments containing Tm5NM1/2 is 
likely to have a very specific impact on the characteristics of these 
filaments. Firstly, the release of actin and Tm5NM1/2 from the pointed 
end will be substantially slowed (82). This is expected to increase both 
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the length and the stability of these filaments. Indeed, studies using 
genetically manipulated mice and cells have shown that the level of 
tropomodulin in the cell can control actin filament length (67, 83). 
Secondly, the isoform-specific interaction between Tmod3 and 
Tm5NM1/2 will ensure that only a specific type of actin filament, based 
on its tropomyosin composition, will be impacted by Tmod3 
phosphorylation. Because the choice of tropomyosin determines the 
functional characteristics of the filament, the initial phosphorylation of 
Tmod3 leads directly to the production of actin filaments with specific 
functional characteristics (79). Indeed, the Tmod3-Tm5NM1 interaction 
is required for efficient insulin-stimulated GLUT4 translocation and 
glucose uptake.  
The findings in this study are further corroborated with the mouse 
genetic and physiology studies conducted in the laboratory of Peter W. 
Gunning (UNSW, Sydney). Overexpression of Tm5NM1 in mice 
increases, and knockout of Tm5NM1 decreases in vivo glucose uptake 
in transversus abdominis (TA) muscle, heart and adipose tissues, 
respectively. Inhibition of Tm5NM1 function by an anti-Tm5NM1/2 drug 
abrogates insulin-stimulated GLUT4 translocation and glucose uptake 
(data not shown). Findings of both mouse and cell-based studies 
clearly support the notion that partnering of Tmod3 with Tm5NM1 is 
important in regulating reorganization of cortical actin filaments, which 




4.3 Future Work 
 
 
As this study mainly applied biochemical and cell biology techniques to 
examine the roles of Tmod3 in insulin-stimulated GLUT4 translocation 
and glucose transport, it is therefore important to study the function of 
Tmod3 at the physiological settings. Previous study (83) by Velia  
Fowler’s group revealed that Tmod1 KO mice have irregular red blood 
cells disrupted of the membrane cytoskeleton. Interestingly, loss of 
Tmod1 in the red blood cells induced a compensatory up-regulation of 
Tmod3 expression. More recently, the same group reported the 
Tmod3-KO mice are embryonic lethal at E14.5-E18.5, most likely due 
to defects in definitive erythropoiesis in the fetal liver (84). Considering 
the roles of Tmod3 in developmental stages, a conditional knockout 
mouse model coupled with a drug-inducible system will be a feasible 























Based on the current study, a working model is proposed to delineate a 
molecular mechanism for insulin signaling to regulate GLUT4 vesicle 
fusion through cortical actin rearrangement, which is at least in part 
mediated by Akt2-induced phosphorylation of Tmod3 (Figure 4). 
Tmod3 readily interacts with Akt2 in the basal state. Upon insulin 
stimulation, both Tmod3 and Akt2 are relocated to PIP3-rich membrane 
microdomains whereby Akt2 becomes activated and in turn 
phosphorylates Tmod3. Phosphorylated Tmod3 cooperates with its 
cognate Tm partner, Tm5NM1 to promote extensive remodeling of both 
membrane and cortical actin filaments, thereby facilitating the insulin-

















Figure 4 Schematic model for Tmod3 as a molecular link between 
Akt2 activation and actin remodeling in insulin-stimulated GLUT4 
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